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Abstract: 
 
 
Antimicrobial Resistance poses a large threat to both human and animal healthcare. 
Antibiotics used on farm are the same or very similar to those used in human healthcare, which 
leads to concerns over the development of resistant organisms. The aim of this study was to 
create resistance profiles of isolates from bovine gut and environment on farms, from 
organisms of medical and veterinary importance.  
Three dairy farms were enrolled for the study. Samples were taken that represented the 
bovine gut and environment. Environmental samples were taken from similar locations across 
all three farms. The antibiograms were produced using the SIRscan 2000 and MICs were 
calculated to begin identifying values for antibiotics that do not have clinical breakpoints in 
veterinary medicine. Amongst the three farms enrolled, 807 strains were isolated, with the most 
prevalent resistance being seen against Tetracycline. Many of the organisms were multi-class 
resistant. Escherichia coli had high MIC values against Tetracyclines that were greater than or 
equal to 64mg/l, correlating with the high levels of resistance seen.  
All farms showed resistance to multiple antibiotics in different classes, the profiles 
varied between the bovine gut and environment on farm and amongst all three farms.  This 
study showed a snapshot of the resistance profiles that can be found. Longitudinal studies 
would provide data as to how resistance changes over time and as exposure to antibiotics 
changes also. By providing information as to what resistance is routinely seen on farm and how 
resistance evolved over time. A better understanding will be gained with greater detail and a 
clearer view of the effects of antibiotic use in the cattle industry.   
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1.0 Introduction: 
 
 Antimicrobials are one of the most important and successful form of 
chemotherapy in modern medicine (Aminov, 2010). It is established that they have 
significantly contributed to the control of infectious disease, allowing certain surgical 
procedures to progress successfully and increase the life expectancy of humans and animals 
worldwide. However, with the overuse of antimicrobials, consequences have arisen. 
Antimicrobial resistance is now a common underlying problem, with multi-drug resistant 
bacteria appearing at an increasing rate imposing significant burdens on healthcare (Hadley 
and Hancock, 2010). Alongside this, development of antibiotics by pharmaceutical companies 
has decreased dramatically, only contributing to around 0.2% of new drug development 
(Spellburg et al., 2010). Novel antibiotic discovery is unlikely to help the issue of antimicrobial 
resistance. Limited antimicrobial drug development will occur compared to other areas of 
healthcare, due to the likelihood that pathogens will evolve resistance to novel antibiotics as 
seen with existing antibiotics (Palmer and Kishony, 2013). For example, Macrolides were 
discovered in 1948, and resistance was first observed in 1955. Aminoglycosides were 
discovered in 1963 and resistance was already being observed in 1964 (Lewis, 2013). It is 
evident that producing new antibiotics will not stop the development of resistant organisms. 
 
1.1 Resistance	Emergence:	
	
Antimicrobial resistance can emerge through transmission of genetic information from one 
bacterium to another (Smilie et al., 2010). This is done in a number of different ways, for 
example, through plasmids and mobile DNA elements. Virtually any gene in intestinal bacteria 
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has the ability to be mobilised and transferred via mobile genetic elements (Smilie et al., 2010). 
Resistance genes can be transferred between bacteria that are in the same species but also 
across different genera (Huddleston, 2014). Under selective pressure, bacteria that carry an 
appropriate resistance gene can become clonally dominant This can be known as Colonisation 
Resistance (CR) (Butaye et al., 2014) and is a mechanism whereby the gut microflora protects 
itself against the arrival of new and often harmful organisms. The use of antibiotics and 
exposure of food animals to antimicrobial agents may increase the number of pathogens in 
animals through reduced CR. This could potentially lead to more pathogens in the food supply 
(Barza, 2010). The risk of foodborne infections could be due to resistant bacteria being able to 
colonize animals or persist in the environment better than susceptible ones (Tollesfon and 
Karp,2004). The widespread use of antibiotics in human and animal medicine is likely to 
induce substantial changes in the gut environment (Sommer et al., 2009). Genes that carry 
resistance, which persist as a result of the antibiotics used could potentially become more 
abundant than others in the human gut microbiome (Butaye et al., 2014). The evidence 
supporting the movement of resistance genes from in the farm environment is shown when 
looking at the flora of farm workers and animals.  When looking at farms that used 
antimicrobial growth promoters, it was seen that there were more resistant bacteria in the 
intestinal microflora of the farm workers and farm animals that those who did not employ this 
practice on farm. Furthermore, a study by Alexander et al. (2010), showed drug resistant 
Escherichia coli (E. coli) was present in or on beef carcasses after evisceration, after 24 hours 
in the chiller and in ground beef for 1-8 days thereafter. It is evident that people on farm and 
those more distantly related to farms practice can become susceptive to resistance found on 
farm (Marshall and Levy, 2011).  
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Under the appropriate selective pressures, bacteria that carry the resistance genes can grow 
and expand at the expense of bacteria that are inhibited (Butaye et al., 2014). Livestock, such 
as cattle, are considered the primary reservoir for bacteria such as non-typhoidal Salmonella 
sp., E. coli and Campylobacter sp. which may cause enteric infections in humans after moving 
through the food chain via improper handling and cooking (Carrattoli, 2008). Extended 
Spectrum Beta Lactamases (ESBLs) are enzymes that have the ability to degrade common 
Penicillins and Cephalosporins. ESBL producing bacteria have been seen in human medicine 
for a long time with new appearances also seen in animal medicine. ESBL producing bacteria 
have frequently been reported in animals but only in the last few years have the same isolates 
been seen in both humans and animals (Carrattoli, 2008). The increase in antimicrobial 
resistance seen in bacteria of animal origin resembles the process in humans seen before (Ewers 
et al., 2012). Evidence like this could suggest that there is an overlap between the ESBL 
positive bacteria found in animals and humans, and therefore there is a possible relationship 
between the two. Within the last decade, the number of publications reporting ESBL 
producing- E. coli isolated from food producing animals has increased (Ewers et al., 2012). 
Noticeably most ESBL enzymes identified in livestock are likewise present in bacteria from 
humans (Smet et al., 2010).  However, the enzyme identified in the different strains of ESBL 
producers does not show a zoonotic link between the two, leaving the question open (Ewers et 
al., 2012). If the same strain was identified, this could be potentially used as evidence to suggest 
a zoonotic link between the two. A better understanding is needed as to what factors contribute 
to the dissemination of resistant microbes among and between humans and animals. This 
includes an evaluation of the role of faecal flora in the dissemination of antimicrobial resistance 
as well as on the mechanisms of linkage and transmissibility of resistance determinants in the 
natural environments (Carrattoli, 2008).  
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In recent studies, including one conducted by Guerra et al (2014), residual resistance was 
found, with bacteria showing to be co resistant to most of the antibiotics used in the study. An 
additional study by Poirel et al (2012), sampled 50 isolates from cattle within a herd, where a 
high prevalence of resistance was seen, particularly to β-lactams as well as Tetracyclines. 
Fischer et al., (2013) took samples from pig farms in Germany and found resistance in 
Salmonella sp. isolates that were studied on farm. The bacteria were shown to be susceptible 
to a broad range of β-lactams and resistant to Chloramphenicol, Streptomycin, Sulphonamides 
and Trimethoprim. It is difficult to follow resistant organisms when no recorded documentation 
is found to follow resistance trends. With different methodologies being used, including 
samples taken at different times in the year and in different geographical areas, the flow of 
ESBL producing E.coli  could not be traced. Detailed knowledge of antimicrobial use should 
be recorded in human, livestock and companion animal medicine (Ewers et al., 2012). This 
could provide a retrospective view on how and when resistance emerged and potentially move 
from livestock to animals. 
1.2 Antimicrobial resistance in the gut: 
 
The human intestinal tract is a reservoir for more antibiotic resistance genes than any other 
studied natural environment such as soil or marine and lake environments (Huddleston, 2014). 
Although it is understood that this potential reservoir can hold resistant organisms, little is 
known about the diversity of the microbes within the BG (Callaway et al., 2014).  The 
microbial community can be classed according to its taxonomy, of which the three most 
dominant phyla observed are Bacteroidetes (such as Bacteroides fragilis), Firmicutes (e.g. 
Bacillus sp.) and Proteobacteria (such as  E. coli) (Jamie & Mizrahi, 2012). Bacteroidetes are 
often the most abundant phyla found in the microbial community in the Bovine Gut (BG), and 
the ratio of Firmicutes to Bacteroidetes is shown to affect energy harvesting and body fat in 
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humans and mice. This is mirrored in cattle, where a decreased presence of Bacteroidetes in 
the microbiota correlates with increased fat in the blood and the tissue. (Turnbaugh et al., 
2006). Although it is possible for the microbiota to have an effect on the animal’s health and 
wellbeing, it does not mean that diet or the environment can alter it. Cows fed the same diets 
have substantial differences in their bacterial communities (Welkie et al., 2010). This suggests 
that microbiota in the bovine gut cannot be presumed.  Research may eventually lead to a full 
understanding of the diversity of the gastrointestinal (GI) flora and how it can be modified. For 
example, a particular microbiome profile in food producing animals could be able to increase 
production efficacy, product quality and/or food safety. This could then be progressed further 
by preventing colonisation of the gut by pathogens, including zoonotic pathogens (Dowd et 
al., 2008). Intestinal E. coli can be readily disseminated in different ecosystems through water 
and are used as indicators of faecal contamination, therefore could also be used to track the 
evolution of antimicrobial resistance within and into different ecosystems (Kummerer., 2009). 
 
Within the phyla of Bacteroidetes, most of the bacteria are anaerobic. The rumen is 
inhabited by a high density of resident microbiota, consisting of bacteria, protozoa, archaea 
and fungi to degrade the plant material (Arumugam et al., 2011). IT acts as a pregastric 
anaerobic chamber of which 95% of its contents is bacteria. (Bruc et al., 2009). While there 
are mostly anaerobic bacteria in the gut, it is the aerobic bacteria that are of concern; zoonotic 
pathogens need to be at least facultative aerobic in order to be a threat to humans. Zoonotic 
pathogenic bacteria such as Salmonella Enterica and E. coli O157 can live in the lower gut of 
cattle and cause human illness through carcass and/or food contamination (Shelton et al., 
2006).  Anaerobic bacteria cannot survive outside the gut, and therefore would not be found in 
faecal samples. Of the aerobic bacteria found in faecal samples, E. coli is most commonly 
detected but represents less than 1% of intestinal bacterial populations (Dowd et al., 2008). 
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Gram negative bacteria, like E. coli, asymptomatically colonise in the guts of birds and 
mammals and the intestinal population differs between animals of the same species. Therefore, 
knowledge regarding E. coli in these intestinal populations is limited to single papers and does 
not represent all species (Guenther et al., 2011). E. coli can grow relatively easily in the 
laboratory unlike the phyla Bacteroidetes, which are fastidious and require specialised 
anaerobic growth conditions. Culture based methods of identification can be time consuming 
and show only 1% of the bacteria present that can be cultured. This leads results to be 
potentially biased in their evaluation of microbial diversity, tending to overestimate the 
importance of bacterial species such as E. coli that easily grow on the agar surface (Dowd et 
al., 2008).  Conducting anaerobic test would help to identify bacteria that are found within the 
intestinal bacterial populations and so would help to stop the over representation of aerobic 
bacteria in studies. 
	
Studies have shown that the environment can also host these pathogens. E. coli identified 
as ESBL producers were seen in the environment decades before ESBL producing E. coli 
outbreaks occurred in human clinical settings (Guenther et al., 2011). The movement of 
antibiotic residues from farm into the environment can lead to the percentage of resistant 
bacteria increasing in the environment. Once administered as much as 30-90% of veterinary 
antibiotics, depending on the class, are excreted into manure (Sarmah et al., 2006). The 
exposure of these antibiotics in the environment causes unnatural pressures on the surrounding 
bacteria leading resistant organisms forming (Sarmah et al., 2006). The transfer of animal 
manure in agricultural soils and spill over from manure lagoons can be found to be a 
predominant source of resistance at farm level (Heuer et al., 2011). When comparing pristine 
soils against agricultural soils, antibiotic resistance differs qualitatively and quantitatively. For 
example, in soil samples taken from the Rocky Mountain National Park in USA, Tetracycline 
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resistance genes were not detected by real time PCR whilst they were abundant in soil samples 
subject to agriculture activities in the same region (Yang et al., 2010).  Originally the frequency 
of bacteria carrying antimicrobial resistant genes in soil was explained by the presence of 
antibiotic producers that harbour these genes to protect themselves from secondary 
metabolites. Antibiotics at low environmental concentrations may have functions other than 
antibiotics including signalling and metabolic purposes (Heuer et al., 2011). Antibiotic-
producing bacteria occur naturally throughout the environment, colonising plants, soil and 
detritus in aquatic environment, aquatic plants and animals. The large-scale mixing of these 
environmental bacteria with exogenous bacteria from anthropogenic sources such as farm 
drainage and waste processing provides the ideal selective and ecological conditions for new 
resistant strains to arise: thus, soil water and other nutrient-enriched habitats can act as hotspots 
for horizontal gene transfer. The reservoir of resistance genes in the environment is due to a 
mix of naturally occurring resistance and those present in animal and human waste and the 
selective effects of pollutants, which can co-select for mobile genetic elements carrying 
multiple resistance genes (Wellington et al., 2013). 
1.3 Antimicrobial Use On Farm: 
Antimicrobials used in animal healthcare are the same or very similar to those given to humans 
(Tollefson and Karp,2004). Antibiotics are mostly used to treat humans after diagnosis, whilst 
in agriculture antimicrobials were also used as a preventative measure in feed, until being 
against the law in the European Union (EU) in 2006, and in treating a whole herd when only a 
few animals showed symptoms (Landers et al., 2012).). Individual animal treatment was seen 
as impractical in large herds so group treatment was preferred when the first and possibly only 
animal showed symptoms (Schwarz et al., 2001). This method of antimicrobial use in animal 
husbandry had been in place since the early 1950s to improve growth and feed efficiency 
(Angulo et al., 2004). There was also the presumption that all antimicrobial growth promoters 
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used developed no cross-resistance with antimicrobials used for human medicine (Schwarz et 
al., 2001). In 1999, using antimicrobials at sub-therapeutic levels for promotion of growth 
came under scrutiny and the World Health Organisation (WHO) recommended discounting 
use if the same antimicrobial classed was used in humans (WHO, 1999). Before the ban was 
proposed, the amount of antibiotics was around 13,288 tons in the EU and Switzerland, of 
which 29% was used in veterinary medicine, 6% used as growth promoters and 65% used in 
human medicine (FEDESA, 2001). In the USA, 70% of the 16,200 tons of antibiotics used was 
in livestock farming, in the same time. This was eight times the amount that was used in human 
medicine (Kummerer, 2003).  To address the issue of inappropriate used of antimicrobial 
agents. Reduction should be facilitated as demonstrated in Denmark and Sweden. The two 
countries showed that dramatically reducing the use of antimicrobial growth promotors with 
human analogues reduced the incidence of antimicrobial resistance and public health risks 
(Angula et al., 2004). Sweden was one of the first countries to discontinue the use of growth 
promoters in 1986 (Cogliani et al., 2011). There was widespread agreement and disagreement 
with this proposed ban: on the one hand, there was the theoretical hazard to human health 
which had arisen from use of growth-promoting antibiotics, however, when examined 
independently without political or commercial influence the risk was seen as very small or 
even zero in many cases (Phillips et al., 2004).  Even though the relationship between antibiotic 
growth promoters and spread of antimicrobial resistance remained unknown, similar resistance 
genes have been isolated from human pathogens, bacteria of animal origin and environmental 
bacteria(Kemper,2008).  
 
The most widely used groups of antibiotics in animal husbandry in the EU are 
Tetracyclines, Macrolides, Penicillins, Aminoglycosides and Sulphonamides (Haller et al., 
2002). Discontinuing the use of these antibiotics as growth promoters was decided in the 
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European Union in 2006, because using antimicrobials in this way potentially stimulates 
selection and dissemination of resistance genes in bacteria (Angula et al., 2009).  Resistant 
bacteria can be transmitted to humans through the consumption or handling of foods of animal 
origin or via direct contact with the animals themselves (Tollesfon and Karp, 2004). 
Discontinuation of antimicrobial growth promoters was seen to lead to a decrease in resistant 
bacteria found in agriculture, food products and humans (Aarestrup et al., 2001). This supports 
a relationship between the two. 
 
Since the EU ban in January 2006, attitudes towards how antibiotics are used on farm 
have changed. Additional pressures from the general public and research has enforced the 
decrease and appropriate use of antimicrobials. More recently the movement from Blanket Dry 
Cow Therapy (DCT) to Selective Dry Cow Therapy (SDCT) has been proposed as an 
additional way to reduce antibiotic use on farm. Antibiotic treatments at the end of lactation, 
DCT, are used to eliminate intramammary infections and prevent new infections during the dry 
period, where the cattle are not milked (Berry and Hillerton, 2002). In many countries DCT is 
a standard way to dry off cows but due to concerns about antibiotic resistance SDCT was 
proposed as an alternative (Huijps and Hogeveen, 2007). This was supported by public pressure 
and consumer concerns about antibiotic residues in milk and antimicrobial resistance levels 
shown through research (Robert et al., 2008).  
 
One of the reasons SDCT was not well received was due to the issue of mastitis 
control as it was believed that antibiotic therapy at the end of lactation was the only and most 
effective way of eliminating infections and preventing new ones (Eberhart, 1986). A study by 
Berry and Hillerton (2002) showed that cows left untreated saw significantly more cases of 
clinical mastitis. Evidence like this suggests that farmers’ attitudes to moving away from 
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antibiotic use would not be positive. Later studies disprove this, for example, a study in 
Denmark (Bennedsgaard et al., 2010) found that their farms participating were able to reduce 
the use of antimicrobials in their herd during the study and after, without apparent negative 
effects on production and udder and herd health. 
 
 A list of critically important antibiotics was introduced in an attempt to control the rise 
of resistant organisms. WHO (2012) created a document for public and animal health 
authorities involved in managing antimicrobial resistance to ensure that the critically or highly 
important antimicrobials listed were used prudently in both human and animal healthcare. 
Among this list were 3rd or 4th Cephalosporins and Fluoroquinolones were mentioned. 
Fluoroquinolones and 3rd generation Cephalosporin are drugs of choice for invasive Salmonella 
sp. infections in humans. Resistant Salmonella sp. resulted from use of antimicrobial agents in 
food animals which can travel to human through the food supply (Angulo et al.,2009). This is 
a possible example to show that certain antibiotic should not be used in animal healthcare, so 
that it can increase the potential to treat effectively in human healthcare. Due to these health 
risks, there is the need to emphasize more prudent treatment with antimicrobials to minimize 
the dissemination of resistant Salmonella sp. (Angulo et al., 2009).  
 
Cefquinome and Marbofloxacin are part of the critically important antibiotics list 
(CIA). According the World Health Organisation (WHO, 2017). This document was created 
to ensure that the antibiotics listed were to be used prudently to help tackle the issue of 
resistance (WHO, 2011). The extended list also includes Tyrosine, Ceftazidime, Tigecycline, 
Ampicillin, Amoxicillin and Gentamicin. This list corresponds to both human and veterinary 
use. Third and fourth generation Cephalosporins which include Cefquinome, Cefotaxime, 
Ceftazidime and Cefepime are some of the antibiotics of highest priority on the CIA list. 
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Table 1 shows which class the antibiotics belong to and which generation the Cephalosporins 
are.  
Table 1: A table of the antibiotics used according to their class. In the cephalosporin table, 
the generation of the antibiotic is put in brackets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The development of resistance in both human and veterinary medicine became the main 
topic of discussion, for example WHO conferences in Berlin (1997) and Geneva (1998). The 
outcome of these discussions was that the use of antimicrobial drugs in humans and animals is 
interrelated and that monitoring systems should be established to focus on resistance in 
pathogenic and commensal bacteria of animal origin (Caprioli et al., 2000). Defined daily dose 
has been considered as the most accurate method in assessing use of antimicrobials. The 
defined daily does refers to the average maintenance dose per day for a drug (WHO,2017). 
Such systems are already seen with supervision of prescribing, dispensing and administration 
in hospital treatment of humans (Hillerton et al., 2016).  The European Medicine Agency 
(EMA) has a method for standardizing antimicrobial sales and annual figures in each country, 
Antibiotic Class Antibiotics 
Cephalosporins Cefoxitin (2nd) 
Cefuroxime (2nd) 
Cefotaxime(3rd) 
Ceftazidime(3rd) 
Cefepime(4th) 
Cefquinome(4th) 
β-Lactams Ampicillin 
Amoxicillin 
Amoxicillin-Clavulanic 
acid 
Piperacillin 
Piperacillin-Tazobactam 
Tetracyclines Oxytetracycline 
Tigecycline 
Fluoroquinolones Ciprofloxacin 
Marbofloxacin 
 
Aminoglycosides Gentamicin 
Carbapenems Ertapenem 
Meropenem 
Imipenem 
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based on the number of animals and their theoretical weight, within each species (Grave et al., 
2012). With this form of regulation, various countries have seen a decrease in antimicrobial 
use in general. New Zealand is this third lowest user of antimicrobials in animal production 
and used much less than in human medicine (Hillerton et al., 2016). In 2010, China was the 
largest antimicrobial consumer for livestock and it is estimated that the industry will use 30% 
of the global antimicrobial production by 2030 (Boeckel et al., 2015). Great lengths are taken 
to decrease the use of antimicrobials, especially in the EU. However, it is projected that 
antimicrobial consumption will rise by 67% by 2030, and nearly double in Brazil, Russia, 
India, China and South Africa. This rise is likely to be due to growth in consumer demand for 
livestock products in middle income countries and a shift to large-scale farms where 
antimicrobials are used routinely (Boeckel et al., 2015). Evidence like this can show the need 
for an international partnership to monitor and control the rise of resistance, as opposed to 
individual countries tackling the issue in numerous different ways. 
 
1.4 Minimum Inhibitory Concentrations (MIC) 
Susceptibility testing is not commonly seen in veterinary medicine as opposed to in 
human medicine. The methods used to distinguish antimicrobial resistance are disc diffusion 
method and/or MIC calculation. MICs are defined as the lowest concentration of an 
antimicrobial that will inhibit growth on an organism (Andrews, 2001).  This can be determined 
by visible growth of an organism, after overnight incubations determined by eye. MICs can be 
used to give a definitive answer when a borderline result is obtained by other methods or when 
disc diffusion methods are not appropriate (Andrews, 2006). An example of this is where 
common veterinary antibiotics, Cefquinome and Oxytetracycline, do not have clinical 
breakpoints published. The European Union Committee for Antimicrobial Susceptibility 
Testing (EUCAST) are one of the main providers for clinical breakpoints to assess the level of 
 18 
resistance within an organism. EUCAST employs certain criteria to determine breakpoints, 
these being: MIC frequency distribution analysis, assessment of MIC values in the context of 
the presence or absence of known mechanisms of resistance, evaluation of MICs based on drug 
levels in patients receiving antibiotic therapy and the response rates in patients with infection 
compared to the drug MICs associated with their infecting pathogens (Doern, 2011). 
 
Marbofloxacin (a Fluroquinolone), Cefquinome (a Cephalosporin) and Oxytetracycline 
(a Tetracycline) are antibiotics used in veterinary practice, but some of these antibiotics are 
commonly used in practice. However, little is known about what resistance is found against 
these antibiotics. The lack of clinical breakpoints determined by EUCAST hinders the 
opportunity to create resistance profiles and hence have a better understanding as what effects 
antibiotic use on farm brings. An example of where MIC values are known is Ampicillin. 
Ampicillin is a well-known β-lactam that is commonly used due to its ability destroys both 
Gram-positive and Gram-negative bacteria (Rozas et al, 2010). The MIC and breakpoint 
values, according to EUCAST, for Ampicillin are already well established. The breakpoint 
value between resistance and susceptibility is 14mm for Enterobacteriacae (EUCAST, 2016) 
in the disc diffusion method.  
 
Evidence has shown that there is a rise in antibiotic resistance due to the overuse of 
antimicrobials in treatment for both human and animal disease. However, attitudes towards the 
way these antimicrobials are being used as changed, as seen in the 2006 ban for them to be 
used as a preventative measure in feed in agriculture. There is still little research to show what 
types of resistance profiles can be shown on the farms. This study will bring to look at what 
resistance can be seen in farm level and discuss whether trends and patterns can be determined. 
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This will help being to bring further understanding as to the effects of antimicrobial use in 
agriculture.   
 
1.5 Aims and Objectives 
 
 The overall aim of the study is to determine the levels of resistance on farms and to 
establish the MIC values of antibiotics without clinical breakpoints to determine the resistance 
level of those antibiotics. This will be done by achieving the following: 
- Isolate	bacteria	from	the	BG	and	Environment	(ENV)	across	three	dairy	farms	enrolled	
in	the	study	
- Identify	the	organisms	isolate	through	a	series	of	biochemical	tests	
- Conduct	antibiograms	against	different	antibiotics	to	test	resistance	
- Compare	resistance	profiles	between	the	farm	and	the	environment	within	the	farm	
and	also	against	the	two	other	farms	involved	
- Calculate	MIC	values	for	E.coli	isolated	on	Farm	1		
- Use	MIC	values	to	calculate	ECOFFs	and	compare	the	values	to	identify	any	resistant	
organisms	for	the	antibiotics	Marbofloxacin,	Cefquinome	an	Oxytetracycline.	
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2.0 Materials and Methods: 
2.1 Farm Enrolment: 
 
Three dairy farms all located in South Central England were enrolled in the study. 
Contact with and enrolment of these farms were made through WestPoint Farm Vets. The 
farms were kept anonymous throughout the study and labelled Farm 1, Farm 2 and Farm 3. 
The sizes of the herds were 300, 200 and 200 respectively and the breed across all three 
farms was Holstein Friesian. The calving status amongst the farms varied: Farm 1 undergoes 
block calving, Farm 2 calves all year round and Farm 3 also undergoes block calving but 
over a longer period of time than Farm 1.  Block calving involves is where all cows within 
the herd are calved at approximately the same time in the year. All herds on the farms were 
on a silage based diet with mixed rations, a common diet to encourage maximum 
performance and health, and had access to grazing at some point throughout the year. 
Samples were taken that represented 30% of the herd. Only 15% of Farm 1 could be 
represented due to the farm leaving the practice half way through the study, due to the farm 
moving practice. All three farms were solely used for milk production, with no other 
livestock present. Samples were collected over a series of visits from October 2015 to March 
2016. Freeze tag numbers and names of environmental locations were used to identify 
samples. This also allowed logging of repeat sample collections from the same cow. Ethical 
approval was not required in this study, due to the cattle not directly being approached for 
sole purpose of the research. The samples were taken during veterinary visits already 
scheduled the inspection gloves taken to isolate samples.  
2.2 Sample Isolation and Identification 
 Bacterial strains from 160 animals present across the three farms were isolated and 
identified. Faecal samples were taken by swabbing of veterinarian examination gloves 
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following rectal examinations. The samples were individually bagged at the location to avoid 
cross contamination of samples. Blue shoe covers were worn to collect samples from the 
holding yard, scraper tractor tread, crush, feed passage and cubicle shed. The samples were 
then taken from the blue shoe covers with swabs to transfer them to the lab. Organisms 
targeted for isolation were E. coli, Salmonella sp., Pseudomonas sp., Klebsiella sp. Proteus 
sp., and Streptococcus sp. These organisms were targeted due to their status in healthcare, 
with common diseases caused by these species. In order to facilitate targeting of these 
organisms, samples were grown on six different agars. The six agars used were: Nutrient agar 
(OXOID), MacConkey agar (OXOID), Brilliant Green agar (OXOID), Modified Edwards 
agar (OXOID), Xylose Lysine Deoxychocolate (XLD) agar (OXOID) and Sorbitol 
MacConkey agar (OXOID). Nutrient agar was used to help growth of the organisms, 
MacConkey agar was chosen to help distinguish bacteria that ferment lactose from those that 
do not. Brilliant Green agar was used to help identify the potential presences of Salmonella 
Sp. Modified Edwards agar is a selective medium for isolation of Streptococcus sp. and XLD 
agar was used as a selective growth medical for differentiation Salmonella Sp. Sorbitol 
MacConkey agar is a variant of MacConkey agar and used for the detection of E. coli 
O157:H7. Results from each agar allowed the different targeted organisms to be isolated after 
overnight growth at 37°C. Isolated samples were then grown on Nutrient and MacConkey 
Agar, which was used as the first step of identification. Gram staining, oxidase, catalase and 
indoles tests were performed. The results from these biochemical tests allowed identification 
of the organisms at a species level.  
 
2.3 Microorganism and culture methods 
 Once all samples were isolated, overnight culture on nutrient agar were transfer to 
Micro bank vials (Pro-lab diagnostics, UK), for storage at -80°C. Isolated were revived by 
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taking from storage and transfer using a sterile swab on Brain Heart Infusion agar and 
incubating aerobically at 37ͦoC for 24 hours before being used. All media used was from 
Oxoid Ltd (Basingstoke, Hampshire UK). Isolates were then stored on microbank beads 
frozen at -80oC. 
 
2.4 Antibiotics used in this study: 
 
 Twenty antibiotics were chosen for the study. All antibiotics were sourced from one 
veterinary practice. The antibiotics were chosen to cover a range of classes, generations and 
be used in both human and veterinary medicine. For the antimicrobial profiles, the antibiotics 
were sub-grouped in groups of 5-6 antibiotics per plates (Table 2). Vet A and Vet B were not 
both used at the same time: Vet A was used for gram negative bacteria and Vet B was used 
for gram positive bacteria. Tylosin can only be used against gram positive bacteria, being 
used in the treatment of Streptococcus and Staphylococcus Sp. Infection (Entorf et al. 2014).  
ESBLA A, ESBLA B and Human plates were used against all samples isolated. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: A table of the antibiotics used separated according to their panels.  The concentrations described are per disc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Panel 
Name: 
Vet A Vet B ESBL A ESBL B Human 
Antibiotics 30µg Cefquinome 
25µg Amoxicillin 
10 µg Ampicillin 
30 µg 
Oxytetracycline 
5 µg Marbofloxacin 
30µg Cefquinome 
25µg Amoxicillin 
10 µg Ampicillin 
30 µg 
Oxytetracycline 
5 µg Marbofloxacin 
30 µg Tylosin 
5 µg Cefotaxime 
10/20 µg Amox/Clav 
30 µg Piperacillin 
30/6 µg Piper/Tazo 
30 µg Cefuroxime 
30 µg Cefoxitin 
10 µg Ceftazidime 
30 µg Cefepime 
10 µg Ertapenem 
10 µg Meropenem 
10 µg Imipenem 
30 µg Ceftazidime 
5 µg Ciprofloxacin 
10 µg Gentamicin 
15 µg Tigecycline 
2.5 SIRscan 2000 
 To establish the resistance profiles of the isolated bacteria, the disc diffusion method 
was used (Kindly provided by Pro Lab Diagnostics and i2a). This disc diffusion method was 
developed in 1940 and is still the official method used in clinical microbiology for routine 
susceptibility testing (Balouiri et al., 2015). It provides qualitative results by using the 
diameter to categorize the reading as susceptible, intermediate or resistant (Jorgensen & 
Ferraro, 2009). The disc diffusion method was done according the EUCAST guidelines 
version 6 (EUCAST,2016) and standard antibiotic discs were used (OXOID) (i2a) (MAST).  
The SIRscan 2000 is an automatic plate reader equipped with the SirWeb programme that 
enables complete management of results (i2a). The plate is put into the SIRscan and a photo 
of the plate is taken which then appears on the screen. Pre-logged light settings and set up of 
antibiotic panels allows the SIRscan to instantaneously read all the zones and interpret them. 
This can then be modified by the user to create readings that are correct for the plate. The 
SIRscan was calibrated at the start of the study. The results are then automatically loaded 
onto a database which can be accessed later. The SIRscan 2000(i2a) is able to automatically 
determine the results of the zones of inhibition through colour co-ordination of 
circumferences (resistant – red, intermediate – yellow, susceptible – green). This is done 
through taking a photo of the plate showing the diameters with an image on the computer. 
The data saved from each plate can be broken down into the qualitative results or ‘raw’ 
diameter readings to allow evaluation of results as desired.  All resistance profiles were 
recorded once. 
2.5 MIC calculation 
All E. coli strains that were taken from Farm 2 were included in this pilot study. E. 
coli was chosen as it was the most common organism isolated throughout the study. A total 
of 85 organisms were used, 39 from visit 1, 32 from visit 2 and 19 from visit 3 (Table 3). 
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The MICs were determined through the method of broth micro dilution. This method 
is susceptibility testing technique, using sterile 96 well micro-dilution plates (VWR), 
inoculated with the organisms, Mueller Hinton broth, and antibiotic at set concentrations 
(Rodriguez-Tudela, 2008). All wells contained 100µl of four times strength Mueller Hinton 
Broth. All antibiotics were diluted in water from powder form (OXOID). 100µl aliquots of 
the antibiotics were then added from well 1-10 through two-fold dilution with the 
concentration starting in well one at 64mg/l the highest concentration to 0.00125mg/l. 
Bacteria suspended in Ringer’s solution at 0.5 McFarland Standard was added at 100µl also 
to wells 1-11 and 100µl sterile ringers solutions were added to well 12. Well 11 acted as a 
positive buffer, containing bacteria only and well 12 acted as a negative bacteria containing 
no bacteria. The plates were kept in a shaking incubator at 80-100rpm at 37°C for 18 hours. 
Each MIC calculation was replicate three times. Turbidity was seen by eye the following day 
by two people and recorded using Microsoft Excel 2016. If turbidity was seen across all wells 
then the MIC was noted as greater than or equal to 64mg/l. However, it is understood that the 
MIC may be higher.  
2.6 Statistical analysis 
In conducting statistical analysis, T tests were performed to analyse the variation 
between groups. Parametric assumptions have been met and t tests were deemed the most 
appropriate method to determine statistical signifigance. Any value under 0.05 is classed as 
significant. Only assumpoions and associations can be made through the trends in the data 
when the results of the t test value does not fall under 0.05. T test were calculated on results 
for organisms showing resistance in relation to species and in relation to antibiotics used.  
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3.0 Results 
3.1 Organisms isolated 
 
The first set of results show the isolation and identification of the isolates taken from 
all three farms, as described in 2.2. The organisms isolated were E.coli, Klebsiella sp., 
Pseudomonas sp., Proteus sp. And Streptococcus sp. Other organisms were also isolated 
throughout the study. These isolates included Corynebacterium sp., Streptobacillus sp, 
Bacillus sp., Enterococcus sp. And Staphylococcus sp. These organisms were put into the 
Other category as part of the results. A breakdown of the isolates taken from farm 1 can be 
shown in table . In total 338 organisms were isolated across the two visits in the study. 69% 
of the isolates were represented in the BG and 31% were represented in the environment. 
E.coli was the most prevalent isolate (72.7% in the BG and 63.1% in the ENV). Samples 
taken from the environmental locations were of a much smaller size than in the BG. These 
observations were seen in Farm 2 and Farm 3, shown in tables 4 and 5 respectively. On Farm 
2, 280 organisms were isolated (table 4). It was visited three times throughout the study. The 
most common organisms isolated on Farm 2 were E.coli (31.2%) and Proteus sp. (32.8%). 
E.coli was the most prevalent in the BG (33%) and Proteus sp. Was the most prevalent in the 
ENV (34.8%). On Farm 3, visited four times throughout the study (table 5), 270 organisms 
were isolated overall. No species from the Other category were isolated. Similar to Farm 1 
and 2, E.coli was isolated the most in the BG (33%), however, Proteus sp. Was isolated the 
most in the ENV (34.8%). 
 
Table 3: Table showing the percentage and number of organisms isolated from Farm 1, separated into organisms isolated per visit and then 
overall and sub grouped into those isolated from the bovine gut, environment and combined. 
 
Species Visit 1 
October 2015 
Visit 2 
November 2015 
Total Number 
(both visits) 
 Location  Location Location 
 Overall Bovine 
Gut 
Environment Overall Bovine 
Gut 
Environment Overall Bovine 
Gut 
Environment 
E.	coli 
92 (80%) 
71	(86%) 21	(66%) 
151 
(67.7%0 107	(70%) 44	(62%) 
243 
(71.8%) 
178 
(75.7%) 
65 (63.1%) 
Pseudomonas	sp. 7 (6.1%) 5	(6%) 2	(6%) 12 (5.4%) 8	(5.5%) 4	(6%) 19 (5.6%) 13 (5.5%) 6 (5.8%)  
Proteus	sp. 10 (8.6%) 2	(2%) 8	(25%) 32 (14.3%) 16	(10%) 16		(21%) 42 (12.4%) 18 (7.6%) 24 (23.3%) 
Streptococcus	sp. 2 (1.7%) 1(1%) 1	(3%) 22 (9.8%)  16	(10%) 6	(9.5%) 24 (7.1%) 17 (7.2%) 7 (6.7%) 
Klebsiella	sp.	 1 (0.8%) 1(1%) 	- 3 (1.3%) 2	(1%) 1	(1.5) 4 (1.1%) 3 (1.2%) 1 (0.9%) 
Staphylococcus	sp.	 1 (0.8%) 1	(1%) 	- 1 (0.4%) 1	(0.5%) 	- 2 (0.6%) 2 (0.8%)  - 
Corynebacterium	sp.		 2 (1.7%) 2	(2%) 	- 2 (0.8%0 2	(1%) 	- 4 (1.1%) 4 (1.6%)  - 
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Table 4: Table showing the percentage and number of organisms isolate from Farm 2, separated into organisms isolated per visit and then 
overall and sub grouped into those isolated from the bovine gut, environment and combined.  
 
 
Species Visit 1 
November 2015 
Visit 2 
January 2016 
Visit 3 
February 2016 
Total Number 
(all visits) 
 
 Source Source Source Source  
 Overall BG ENV Overall BG ENV Overall BG ENV Overall BG ENV 
E.	coli 38 (40%) 31	(41%) 7	(37%) 
32 (39%) 
26	(44%) 6	(26%) 
19 (18.4%) 
14	(18%) 5	(22%) 
89 (31.2%) 71 (33%)  18(27%) 
Pseudomonas	sp. 5 (5.2%) 2	(3%) 3	(18%) 5 (6%) 3	(5%) 2	(9%) 5 (4.8%)  5	(6%) 	- 15 (5.3%) 10 (4.6%) 5 (7.5%) 
Proteus	sp. 
30 
(31.6%) 24	(32%) 6	(32%) 
17 
(20.7%) 10	(17%) 7	(30%) 
45 (43.6%) 
35	(44%) 10	(44%) 
92 (32.8%) 69  
(32.2%) 
23 
(34.8%) 
Streptococcus	sp. 
16 
(16.8%) 13	(17%) 3	(16%) 
23 (28%) 
18	(31%) 5	(22%) 
24 (23.3%) 
18	(22%) 6	(26%) 
63 (22.5%) 49 (22.8%) 14 (21%) 
Klebsiella	sp.	 6 (6.3%) 5	(7%) 1	(6%) 5 (6.1%) 2	(3%) 3	(13%) 3 (2.9%) 3	(3%) 	- 14 (5%) 10 (4.6%) 4 (6%) 
Staphylococcus	sp.	  -  -  -  -  -  - 2 (1.9%) 1	(1%) 1	(4%) 2 (0.7%) 1 (0.4%) 1 (1.5%) 
Enterococcus	sp.	  -  -  -  -  -  - 3 (2.9%) 3	(3%) 	- 3 (1.1%) 3 (!.2%)  - (0%) 
Corynebacterium	sp.	  -  -  -   -  -  - 2 (1.9%)  1	(1%)	 1	(4%) 2 (0.7%) 1 (0.4%)  1 (1.5%) 
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Table 5: Table showing the percentage and number of organisms isolate from Farm 3, separated into organisms isolated per visit and then 
overall and sub grouped into those isolated from the bovine gut, environment and combined.   
 
Species Visit 1 
January 2016 
Visit 2 
February 2016 
Visit 3 
March 2016 
Visit 4 
March 2016 
Total Number 
(all visits) 
 Source Source Source Source Source 
 
Overall BG ENV Overall BG ENV Overall BG ENV Overa
ll 
BG ENV Overall BG ENV 
E.	coli 
32  
(55%) 19	
(57%) 
13	
(52%) 
25 
(37.8) 19	
(38%) 
9		
(47%) 
37 
(47%) 32	
(59%) 
5		
(22%) 
30 
(44.7%
) 
24	
(48%) 
6		
(35%) 
127 
(47%) 
94 
(50%) 
33 
(39%) 
Pseudomonas	sp. 
4  
(6.8%) 	- 
4	
(16%) 
14 
(21.2%) 
9	
(18%) 
5		
(26%) 
9  
(11.5%) 	- 
9		
(39%) 
3 
(4.4%) 	- 
3		
(18%) 
30 
(11%) 
9 
(4.8%) 
21 
(25%) 
Proteus	sp. 
6  
(10.3%) 
5	
(15%) 1	(4%) 
13 
(19.6%) 
10	
(20%) 
3		
(16%) 
22 
(28%) 
14	
(26%) 
6		
(26%) 
17 
(25%) 
13	
(26%) 
4		
(23.5%) 
56 
(21%) 
42 
(22.4%) 
14 
(16.8%) 
Streptococcus	sp. 
11  
(18.9%) 
7	
(21%) 
4	
(16%) 
10 
(15%) 
9		
(18%) 
1		
(5%) 
7 
(8.9%) 
6	
(11%) 
1		
(4%) 
17 
(25%) 
13	
(26%) 
4		
(23.5%) 
45 
(9.2%) 
35 
(18.7%) 
10 
(12%) 
Klebsiella	sp. 
5  
(8.6%) 2	(6%) 
3	
(12%) 
4 
(6%) 
3		
(6%) 
1		
(5%) 
3 
(3.8%) 
2		
(4%) 
1		
(4%) 
 -  -  - 12 
(4.4%) 
7 
(3.7%) 
5 
(6%) 
Staphylococcus	
sp. 
 -  -  -  -  -  -  -  -  -  -  -  -  -  -  - 
Corynebacterium	
sp.	 
 -   -  -  -  -  -  -  -  -  -  -  -  -  - 
 
 
 
 
 
 
 
 
3.2 Antibiotic resistance in relation to species 
 
 
Once the organisms were isolated and identified, resistance profiles were created 
according to the method described in 2.3 and 2.4. Manual and SIRscan readings were used to 
determine which organism were resistant to antibiotics. This was then analysed to note which 
organisms showed resistance to certain classes of antibiotics and whether the organism 
showed resistance to more than one class. The locations were separated to BG and ENV only, 
where all the separate environmental locations represented one environmental sample. 
 
 Farm 1 showed a higher prevalence of organisms that were resistant to two or more 
classes of antibiotic (table 6). This is especially true for Klebsiella sp. And specie from the 
“Other” category. Multi-class resistance is more common in the samples from the ENV 
across all farms.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 6: Table showing the number and percentage of targeted bacterial organisms that show resistance within the bovine gut, environment and 
overall on Farm 1 
 
  E.coli Proteus Pseudomonas Streptococcus  Klebsiella Other 
B
ov
in
e 
G
ut
 
 Visit 1 Visit 2 Overall Visit 1 Visit 2 Overall Visit 1 Visit 
2 
Overall Visit 
1 
Visit 2 Overall Visit 1 Visit 2 Overall Visit 1 Visit 2 Overall 
No 
Resistance 
5  
(11%) 
21 
(27%) 
26 
(22%) 
1 
(7%) 
- 1 
(6%) 
- 1 
(20%) 
1 
(16%) 
- - - 1 
(100%) 
- 1 
(50%) 
- - - 
Resistance 
to one 
class 
11 
(26%) 
29 
(38%) 
40 
(33.4%) 
3 
(21%) 
2 
(100%) 
5 
(30%) 
- 2 
(40%) 
2 
(32%) 
4 
(40%) 
- 4 
(26%) 
- - - - - - 
Resistance 
to 2+ 
classes 
26 
(62%) 
26 
(34%) 
52 
(44%) 
9 
(69%) 
- 9 
(64%) 
2 
(100%) 
2 
(40%) 
4 
(64%) 
6 
(60%) 
5 
(100%) 
11 
(74%) 
- 1 
(100%) 
1 
(50%) 
- 1 
(100%) 
1 
(100%) 
E
nv
ir
on
m
en
t 
 Visit 1 Visit 2 Overall Visit 1 Visit 2 Overall Visit 1 Visit 
2 
Overall Visit 
1 
Visit 2 Overall Visit 1 Visit 2 Overall Visit 1 Visit 2 Overall 
No 
Resistance 
- - - - - - - - - - - - - - - - - - 
Resistance 
to one 
class 
1 
(7%) 
1 
(4.7%) 
2 
(5.5%) 
- - - - - - - - - - - - - - - 
Resistance 
to 2+ 
classes 
13 
(93%) 
20 
(95.3%) 
33 
(94.5%) 
8 
(100%) 
8 
(100%) 
16 
(100%) 
3 
(100%) 
- 3 
(100%) 
- 1 
(100%) 
1 
(100%) 
1 
(100%) 
- 1 
(100%) 
1 
(100%) 
- 1 
(100%) 
O
ve
ra
ll 
 Visit 1 Visit 2 Overall Visit 1 Visit 2 Overall Visit 1 Visit 
2 
Overall Visit 
1 
Visit 2 Overall Visit 1 Visit 2 Overall Visit 1 Visit 2 Overall 
No 
Resistance 
5 
(8.9%) 
21 
(22%) 
26 
(16.9%) 
1 
(4.7%) 
- 1 
(3.2%) 
- 1 
(20%) 
1 
(10%) 
- - - 1 
(50%) 
- 1 
(33%) 
- - - 
Resistance 
to one 
class 
12 
(21.4%) 
30 
(31%) 
42 
(27.4%) 
3 
(14.2%) 
2 
(20%) 
5 
(16%) 
- 2 
(40%) 
2 
(20%) 
4 
(40%) 
- 4 
(25%) 
- - - - - - 
Resistance 
to 2+ 
classes 
39 
(69%) 
46 
(47%) 
85 
(55.5%) 
17 
(81%) 
8 
(80%) 
25 
(81%) 
5 
(100%) 
2 
(40%) 
7 
(70%) 
6 
(60%) 
6 
(100%) 
12 
(72%) 
1 
(50%) 
1 
(100%) 
2 
(66.6%) 
1 
(100%) 
1 
(100%) 
2 
(50%) 
Table 7:  Table showing the number and percentage of E.coli, Proteus sp. and Pseudomonas sp. that show resistance within the bovine gut, 
environment and overall on Farm 2 
 
  E.coli Proteus sp. Pseudomonas sp. 
B
ov
in
e 
G
ut
 
 Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall 
No Resistance 43% 69% 42& 26% 9% 75% 9% 31% 0% 33% 0% 33% 
Resistance to 
one class 
29% 23% 29% 19% 40% 12.5% 40% 31% 0% 
 
33% 0% 33% 
 Resistance to 
2+ classes 
29% 8% 29% 55% 51% 12.5% 51% 38% 0% 33% 0% 33% 
E
nv
ir
on
m
en
t 
 Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall 
No Resistance 22.33% 67% 0% 0% 40% 100% 20% 53% 0% 0% 0% 0% 
Resistance to 
one class 
53.1% 16.5% 100% 43% 19% 0% 40% 16.3% 16% 50% 50%  
39% 
Resistance to 
2+ classes 
24.5% 16.5% 0% 57% 41% 0% 40% 26.7% 67% 50% 50% 61% 
 
 Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall 
O
ve
ra
ll 
No Resistance 40.67% 69% 32% 13% 32% 71% 11% 38% 7% 20% 0% 9% 
Resistance to 
one class 
31% 22% 47% 31% 31% 18% 49% 33% 52% 40% 50% 47% 
Resistance to 
2+ classes 
28.33% 9% 21% 56% 27% 12% 40% 29% 41% 40% 50% 44% 
Table 8: Table showing the percentage of Streptococcus sp., Klebsiella sp. and species from the Other category that show resistance within the 
bovine gut, environment and overall on Farm 2. 
 
  
  Streptococcus sp. Klebsiella sp. Other 
B
ov
in
e 
G
ut
 
 Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall 
No Resistance 0% 39% 83% 41% 85% 0% 0 28% 0% 0% 0% 0% 
Resistance to 
one class 
50% 17% 17% 28% 17% 0% 50% 22% 0% 0% 0% 0% 
Resistance to 
2+ classes 
50% 44% 0% 31% 0% 0% 50% 50% 100% 0% 100% 100% 
E
nv
ir
on
m
en
t 
 Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall 
No Resistance 0% 60% 80% 47% 83% 0% 0% 28% 0% 0% 0% 0% 
Resistance to 
one class 
50% 20% 10% 27% 17% 0% 0% 6% 0% 0% 100% 50% 
Resistance to 
2+ classes 
50% 20% 10% 26% 0% 100% 0% 66% 100% 0% 0% 50% 
O
ve
ra
ll 
 Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 3 Overall Visit 1 Visit 2 Visit 2 Overall 
No Resistance 44% 43% 77% 55% 31% 0% 33% 21% 0% 0% 0% 0% 
Resistance to 
one class 
31% 17% 18% 22% 33% 0% 33% 22% 0% 0% 50% 25% 
Resistance to 
2+ classes 
33% 40% 5% 23% 35% 100% 33% 57% 100% 0% 50% 75% 
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Table 9: Table showing the number and percentage of E.coli, Proteus sp. and Pseudomonas sp. that show resistance within the bovine gut, 
environment and overall on Farm 3 
 
  E.coli Proteus sp. Pseudomonas sp. 
B
ov
in
e 
G
ut
 
 Visit 1 Visit 
2 
Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3 Visit 4 Overall 
No 
Resistance 
(11.25%) 0% 3% 4% 4.5% 7.25% 0% 29% 0% 9% 0% 0% 33% 0% 8.25% 
Resistance 
to one 
class 
(33.5%) 32% 38% 33% 34% 21.25% 0% 14% 38% 18% 0% 0% 17% 0% 4.25% 
Resistance 
to 2+ 
classes 
(55.25%) 68% 59% 63% 61.5% 71.25% 100% 57% 62% 73% 0% 100% 50% 0% 87.5% 
E
nv
ir
on
m
en
t 
 Visit 1 Visit 
2 
Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3 Visit 4 Overall 
No 
Resistance 
(7.75%) 0% 0% 0% 1.9% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 
Resistance 
to one 
class 
(46.5%) 33% 80% 25% 46.1% 50% 75% 0% 25% 37.5% 32.75% 20% 11% 25% 22% 
Resistance 
to 2+ 
classes 
(48%) 66% 20% 75% 52% 50% 25% 100% 75% 62.5% 67.25% 80% 89% 75% 78% 
O
ve
ra
ll 
 Visit 1 Visit 
2 
Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3 Visit 4 Overall 
No 
Resistance 
11.75% 0% (3%) 2%  
4.25% 
13.25% 0% 20% 0% 3% 0% 0% 16% 0% 4% 
Resistance 
to one 
class 
34.75% 32% 
 
43% 26% 34% 17% 33% 10% 26% 22% 31.25% 10% 14% 25% 20% 
Resistance 
to 2+ 
classes 
53.5% 68% 54% 72% 61.75% 67% 66% 70% 64% 75% 70.75% 90% 70% 75% 76% 
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Table 10: Table showing the percentage of Streptococcus sp., Klebsiella sp. and species from the Other category that show resistance within the 
bovine gut, environment and overall on Farm 3 
 
 
 
  Streptococcus sp. Klebsiella sp. Other 
B
ov
in
e 
G
ut
 
 Visit 1 Visit 2 Visit 3 Visit 
4 
Overall Visit 1 Visit 2 Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3 Visit 4 Overall 
No Resistance 19.75% 0% 33.5% 46% 24% 12.5% 0% 50% 0% 3% 0% 0% 0% 0% 0% 
Resistance to 
one class 
18% 12.5% 16.5% 23% 17.5% 29% 66% 0% 0% 23.75% 2
5
% 
0% 0% 100% 100% 
Resistance to 2+ 
classes 
62.25% 87.5% 50% 31% 57% 33.25% 33% 50% 0% 29.25% 0% 0% 0% 0% 0% 
E
nv
ir
on
m
en
t 
 Visit 1 Visit 2 Visit 3 Visit 
4 
Overall Visit 1 Visit 2 Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3 Visti 4 Overall 
No Resistance 37.5% 0% 100% 50% 47% 0% 0% 50% 0% 12.5% 0% 0% 0% 0% 0% 
Resistance to 
one class 
0.5% 0% 0% 0% 0.1% 43.75% 0% 0% 0% 11% 0% 0% 0% 100% 100% 
Resistance to 2+ 
classes 
37.75% 100% 0% 50% 52.9% 56.25% 100% 50% 0% 76.5% 0% 0% 0% 0% 0% 
O
ve
ra
ll 
 Visit 1 Visit 2 Visit 3 Visit 
4 
Overall Visit 1 Visit 2 Visit 3 Visit 4 Overall Visit 1 Visit 
2 
Visit 3  Overall 
No Resistance 29.25% 0% 66% 48% 35.8% 6.25% 0% 50% 0% 14% 50% 0% 0% 0% 0% 
Resistance to 
one class 
17.5% 6% 8% 11% 10.6% 33.75% 33% 0% 0% 16% 50% 0% 0% 100% 100% 
Resistance to 2+ 
classes 
53.25% 93% 26% 41% 53.6% 35% 66% 50% 0% 70% 0% 0% 0% 0% 0% 
 
 Separating the data between the BG and ENV showed where the resistance can be 
found. Across all three farms, resistance was seen in organisms across the BG and ENV. 
However, the profiles of resistance was different across all three farms.  
 All cows included in the study were deemed “healthy” with no cases on ongoing 
treatment and all the farm locations were cleaned on a regular basis. However, isolates from 
each farm show a different resistance profile, which could reflect farm antimicrobial use as 
well as exposure to movement of resistant organisms and lack of biosecurity. Biosecurity 
refers to the measure designed to reduce the risk of transmission of organisms. An example 
of this in this instance would be wildlife, like birds that fly on and of the farm and 
neighbouring fields.  
 Resistant organisms can more from the BG and ENV and visa versa. The difference 
between the resistance found in the BG and ENV means that one cannot be representative of 
another or used to be representative of the overall resistance pattern. Further work is needed 
to determine for the resistance can more from the BG to the ENV or the other way around.  
Resistance profiles were then measured according to resistance against each antimicrobial 
tested.  
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3.3 Class Resistance 
 
 Comparing the resistance profiles on each farm, in the BG and ENC allowed a more 
direct comparison between the levels of resistance seen. When focusing on Farm 1, the 
profiles vary greatly between the BG and ENV. For example, the resistance profile for E.coli 
showed higher resistance levels to Cephalosporins (46%), b-lactams (51%) and Tetracyclines 
(88.5%) in the ENV (table 7) than in BG (8%, 14% and 72% respectively). For all species in 
both the BG and ENV, the most frequently observed resistance was against the Tetracycline 
class, although the percentages vary slightly 100% of the Klebsiella sp. In the ENV were 
resistant to tetracycline, whereas 50% of resistance against tetracycline was seen in the BG. 
This pattern of higher resistance in the ENV compared to the BG was true for all species on 
Farm 1. 
 
Table 11: Table showing the percentage of bacteria that is resistant to classes of antibiotics in the BG, ENV and overall for Farm 1 
 
 
	 		 E.coli	(%)	 Proteus	sp.	(%)	 Pseudomonas	sp.(%)	 Streptococci	sp.	(%)	 Klebsiella	sp.	(%)	
O
ve
ra
ll	
Cephalosporin	 18	 26	 17	 0	 0	
Beta	Lactams	 22	 26	 33	 9	 33	
Aminoglycoside	 26	 29	 33	 32	 33	
Tetracyclines	 75	 91	 83	 59	 66	
Carbapenems	 2	 12	 8	 0	 0	
Fluoroquinolone		 4	 12	 0	 18	 0	
Macrolide	 0	 0	 0	 23	 0	
	 	 E.coll	(%)	 Proteus	sp.(%)	 Pseudomonas	sp.	(%)	 Streptococci	sp.	(%)	 Klebsiella	sp.	(%)	
Bo
vi
ne
	G
ut
	
Cephalosporin	 8	 19	 12	 0	 0	
Beta	Lactams	 14	 12	 12	 6	 0	
Aminoglycoside	 28	 31	 38	 25	 50	
Tetracyclines	 72	 93	 75	 50	 50	
Carbapenems	 3	 63	 0	 0	 0	
Fluoroquinolone		 0	 0	 0	 19	 0	
Macrolide	 0	 0	 0	 6	 0	
	 	 E.coli	(%)	 Proteus	sp.	(%)	 Pseudomonas	sp.	(%)	 Streptococci	sp.	(%)	 Klebsiella	sp.	(%)	
En
vi
ro
nm
en
t	
Cephalosporin	 46	 38	 25	 0	 0	
Beta	Lactams	 51	 31	 75	 17	 100	
Aminoglycoside	 20	 25	 25	 50	 0	
Tetracyclines	 86	 88	 100	 83	 100	
Carbapenems	 0	 19	 25	 0	 0	
Fluoroquinolone		 11	 12	 0	 17	 0	
Macrolide	 0	 0	 0	 50	 0	
The most prevalent resistance towards an antibiotic class differs on Farm 2 (table 12) 
compared to Farm 1. Like Farm 1, E.coli, Pseudomonas sp., Klebsiella sp., and species from 
the Other category showed most resistance to Tetracycline (43%, 37%,  33% and 75% 
respectively). Proteus sp. Overall showed more resistance to Cephalosporin (27%) but 
Proteus sp. isolates from the ENV saw higher resistance to Tetracycline. Pseudomonas sp. 
isolated from the BG showed a higher resistance prevalence to Tetracycline. Klebsiella sp. 
showed a similar pattern, higher resistance was observed against   b-lactams (40%) in the BG 
rather than Cephalosporin.  
Species from the “Other” category were not isolated in Farm 3 (table 13). On Farm 3, across 
the BG and ENV, the highest level of resistance was observed against Tetracyclines, as seen 
on the other two farms. On the other two farms, differences were seen in the resistance 
profiles between the BG and ENV, whereas on Farm 3 more similarities can be seen. Unlike 
Farm 1 and Farm 2, a trend of high prevalence of resistance against the antibiotics in the 
ENV compared to the BG was not shown in the results for Farm 3. 
 
 
 
 
 
Table 12: Table showing the percentage of bacteria that is resistant to classes of antibiotics in the BG, ENV and overall for Farm 2 
 
	 		 E.coli	(%)	 Proteus	sp.		(%)	 Pseudomonas	sp.		(%)	 Streptococci	sp.		(%)	 Klebsiella	sp.	(%)	 Other	(%)	
O
ve
ra
ll	
Cephalosporin	 24	 27	 18	 2	 22	 0	
Beta	Lactams	 17	 23	 26	 9	 27	 25	
Aminoglycoside	 3	 9	 0	 25	 0	 0	
Tetracyclines	 43	 18	 37	 22	 33	 75	
Carbapenems	 11	 18	 18	 0	 16	 0	
Fluoroquinolone	 9	 4	 0	 18	 0	 0	
Macrolide	 0	 0	 0	 24	 0	 0	
	 		 E.coli	(%)	 Proteus	sp.	(%)	 Pseudomonas	sp.	(%)	 Streptococci	sp.	(%)	 Klebsiella	sp.		(%)	 Other	(%)	
Bo
vi
ne
	G
ut
	
Cephalosporin	 27	 18	 33	 19	 10	 0	
Beta	Lactams	 17	 16	 13	 5	 40	 50	
Aminoglycoside	 3	 4	 0	 24	 0	 0	
Tetracyclines	 47	 41	 40	 14	 40	 50	
Carbapenems	 7	 14	 13	 0	 10	 0	
Fluoroquinolone	 0	 5	 0	 16	 0	 0	
Macrolide	 0	 0	 0	 21	 0	 0	
	 		 E.coli	(%)	 Proteus	sp.		(%)	 Pseudomonas	sp.	(%)	 Streptococci	sp.		(%)	 Klebsiella	sp.		(%)	 Other	(%)	
En
vi
ro
nm
en
t	
Cephalosporin	 26	 21	 15	 0	 38	 0	
Beta	Lactams	 19	 16	 36	 16	 12	 0	
Aminoglycoside	 6	 14	 0	 0	 0	 0	
Tetracyclines	 33	 33	 27	 67	 25	 100	
Carbapenems	 10	 14	 22	 0	 25	 0	
Fluoroquinolone	 3	 3	 0	 16	 0	 0	
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Table 13: Table showing the percentage of bacteria that is resistant to classes of antibiotics in the BG, ENV and overall for Farm 3 
 
 
	 		 E.coli	(%)	 Proteus	sp.		(%)	 Pseudomonas	sp.		(%)	 Streptococci	sp.		(%)	 Klebsiella	sp.	(%)	
O
ve
ra
ll	
Cephalosporin	 27	 25	 10	 0	 12	
Beta	Lactams	 21	 19	 30	 13	 48	
Aminoglycoside	 4	 3	 0	 20	 0	
Tetracyclines	 35	 35	 30	 20	 24	
Carbapenems	 11	 13	 30	 0	 12	
Fluoroquinolone	 1	 6	 0	 10	 0	
Macrolide	 0	 0	 0	 37	 0	
	 		 E.coli	(%)	 Proteus	sp.	(%)	 Pseudomonas	sp.	(%)	 Streptococci	sp.	(%)	 Klebsiella	sp.		(%)	
Bo
vi
ne
	G
ut
	
Cephalosporin	 28	 25	 0	 0	 0	
Beta	Lactams	 22	 22	 0	 11	 50	
Aminoglycoside	 2	 1	 0	 22	 0	
Tetracyclines	 40	 27	 100	 19	 33	
Carbapenems	 8	 16	 0	 0	 17	
Fluoroquinolone	 0	 7	 0	 11	 0	
Macrolide	 0	 0	 0	 37	 0	
	 		 E.coli	(%)	 Proteus	sp.		(%)	 Pseudomonas	sp.	(%)	 Streptococci	sp.		(%)	 Klebsiella	sp.		(%)	
En
vi
ro
nm
en
t	
Cephalosporin	 24	 24	 12	 0	 50	
Beta	Lactams	 24	 24	 36	 33	 50	
Aminoglycoside	 9	 12	 0	 0	 0	
Tetracyclines	 22.5	 24	 12	 33	 0	
Carbapenems	 14	 12	 36	 0	 0	
Fluoroquinolones	 4.5	 6	 0	 0	 0	
	 Macrolide	 0	 0	 0	 33	 0	
 
Across all three farms the percentage of tetracycline resistance exceeded all other 
classes. More variation in the farm’s resistance profiles was seen when comparing the class 
that had the second most prevalent level of resistance. In Farm 1, resistance was shown to be 
present against Aminoglycosides. This is true for all species (E. coli 28%, Pseudomonas sp. 
38%, Streptococcus sp. 25% and Klebsiella sp. 50%) except species from the Other category.  
This differs to the profile seen in Farm 2, where different results were seen for the second most 
prevalent. Overall, Proteus sp. (28%), Pseudomonas sp. (47%), Klebsiella sp. (36%) and 
species from the Other category (25%) showed the class to be β-Lactams. E. coli had the result 
for the Cephalosporin class at 29% and Streptococcus sp. showed it for Macrolides (24%).  
While on Farm 1 the same pattern was seen in the BG and ENV, the trend in the BG of Farm 
2 differs to the profile in the ENV. Within the BG, E. coli (44%), Proteus sp. (32%) and 
Pseudomonas sp. (33%) had Cephalosporin as the second most resistant class. Klebsiella sp. 
and species from the Other category saw it for Aminoglycosides and Streptococcus sp. (29%) 
saw it from Macrolides again. In the ENV, again E. coli (44%) and Proteus sp. (33%) has this 
result for Cephalosporins, but this time Tetracyclines were the second most prevalent for 
Pseudomonas sp. (57%)and Klebsiella sp. (50%). 
In Farm 3, E. coli showed the class with the second highest resistance to be 
Aminoglycosides, in the BG (56%) and in the ENV (64%). β-Lactam resistance against Proteus 
sp. in the ENV (50%), which was the second most prevalent resistance in the ENV, differing 
to the BG, where the class was Aminoglycosides.  Within the Pseudomonas sp. isolated on 
Farm 3, resistance against Cephalosporins and β-Lactams was at 46%. In the ENV the second 
most resistant class was against Streptococcus sp. (30%). The resistance profile on Farm 3 had 
the most similarity to the profile seen in Farm 1. However, there were still notable differences 
between all three farms. The differences in the resistance profiles mean that no conclusions can 
be made to draw relationships between the three farms.   
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Within the Gram negative species, the least prevalent resistant was seen against 
Carbapenems and Fluoroquinolones as seen in Farm 1 (table 7). This was also the case for 
Farm 3 (table 9). Within Farm 2, more variability was seen across the species. All farms show 
the least resistance against the Fluoroquinolone class within the Gram negatives. In Farm 3, 
low levels of resistance were also seen against Aminoglycosides (4% for E. coli and 11% for 
Proteus sp.). Higher resistance were seen against Aminoglycosides in Pseudomonas sp. The 
second lowest percentage of resistance was seen against Carbapenems and Cephalosporins, 
with the result of 33%. The classes Carbapenems and Cephalosporin had the lowest 
percentages of resistance in Farm 3. However, the result of 33% resistance against classes in 
Farm 1 and 2 coincided with the highest levels of resistance. The proportional difference of 
percentage across all three farms suggest the different AMR profiles present. Again, these 
differences in the percentage of resistance and the ration of different resistance percentages 
show a different profile in the three farms. At this point no relationships can be drawn between 
the resistance found in the BG or ENV and the three farms enrolled showed little similarity. 
3.4 Statistical comparison of organisms in relation to organisms and anitbiotics 
 
Tables 14-16 shows the value for the t tests performed when comparing the 
percentage of resistance values in the bovine gut versus the environment, and between farms.  
 
Table 14: T test values for the bovine gut results versus the environmental results on Farm 
1,2 and 3. 
 
Organism Farm 1 Farm 2 Farm 3 
E.coli 0.060101725	
	
0.408737345	 0.465913814	
Proteus sp. 0.466915818	
 
0.422189883	
 
0.386183692 
Pseudomonas sp. 0.068838902	
 
0.489566677	
 
0.486156737 
Streptococcus sp. 0.030996228	
 
0.384084824	
 
0.490176826 
Klebsiella sp.  0.228525824	
 
0.5	
 
0.5 
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Values that fall below 0.05 are statistically significant. This is only true for 
Streptococuss sp. On Farm 1. The remaing values fall above this are not stastically significant 
and therefore only assumptions of the data cannot be made. For Table 15,no values fell below 
0.05 and for Table 16 only E.coli and Proteus sp. Showed significant signifigance. 
 
Table 15: T Test results for the BG from farm to farm comparisons 
Organism Farm 1 v Farm 2 Farm 1 v Farm 3 Farm 2 v Farm 3 
E.coli 0.296690835 0.315746846 0.459668934 
Proteus sp. 0.061162349 0.093969783 0.5 
Pseudomonas sp. 0.274562826 0.244516364 0.495002422 
Streptococcus sp. 0.443131179	
 
0.452776233 0.486675404	
 
Klebsiella sp.  0.5	
 
0.5 0.5 
 
Table 16: T test results for ENV for farm to farm comparisons 
Organism Farm 1 v Farm 2 Farm 1 v Farm 3 Farm 2 v Farm 3 
E.coli 0.038490983 0.06368379 0.473157762 
Proteus sp. 0.027314799 0.050913731 0.473512955 
Pseudomonas sp. 0.038981693	
 
0.067176568 0.433362068 
Streptococcus sp. 0.111267863 0.064283016 0.433362068 
Klebsiella sp.  0.235908297 0.228525824 0.276363088 
 
T test were also performed data showing the number of organisms that were resistance to 
none, one of two or more antibiotics. Tables 17 – 20 showed comparisons between farms. No 
values fell below 0.05 which means that only assumptions of the data can be made and values 
did not show to be significantly significant. 
Table 17: T test results for bacteria showing resistance for Farm 1 against Farm 2 
 E.coli Proteus sp.  Pseudomonas sp. Streptococci sp. Klebsiella sp. 
No Resistance 0.4841807	 0.5	 0.393897877	 0.5 0.5 
Resistant to 1 0.5	 0.484382014	 0.5 0.5 0.5 
Resistant to 2+ 0.444049149	 0.5	 0.5 0.5 0.489158578	
  
Table 18: T test results for bacteria showing resistance on Farm 2 against Farm 3 
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 E.coli Proteus sp.  Pseudomonas sp. Streptococci sp. Klebsiella sp. 
No Resistance 0.5	 0.5	 0.495692375	 0.486794772	 0.11169752	
Resistant to 1 0.232192631	 0.478693096	 0.5	 0.499242583	 0.5	
Resistant to 2+ 0.5 0.468408799	 0.5	 0.5	 0.5	
 
Table 19: T test results for bacteria showing resistnance on Farm 1 against Farm 3 
 E.coli Proteus sp.  Pseudomonas sp. Streptococci sp. Klebsiella sp. 
No Resistance 0.488345273	 0.5	 0.408201491	 0.485855978	 0.276370099	
Resistant to 1 0.116060216	 0.5	 0.5	 0.499565694	 0.5	
Resistant to 2+ 0.480471759	 0.5	 0.5	 0.5	 0.488526193	
  
The results of the t tests in overall show few results are statistically significant which meant 
only assumptions of the results could be made.  
3.4 Determining ECOFFS 
Epidermiological cut-off values (ECOFFs) were used to identify the upper limit of wild type 
(WT) population. For Marbofloxacin (Figure 14) the value was 8mg/l; for Oxytetracycline 
(Figure 15) the value was 16mgl. For Ampicillin the ECOFF was 16mg/l and Cefquinome 
(Figre 17) had the value of 8mg/l.  
 The ECOFFs were determined from MICs of all E.coli  on Farm 1 in the study. With 
a smaller sample size. When looking at the graphs, estimates can be determined. Ampicillin 
has the same ECOFF value as Oxytetracycline, with Cefquinome and Marbofloxacin having 
lower ECOFF values at 8mg/l. The next stage was to compare the Zone Diamter (ZD) values 
with the MICs to determine any correlation between the two value.
  
Figure 1: Bar chart showing distribution analysis of MIC values for Marbofloxacin. The black arrow represents with the ECOFF cut off value is 
(8mg/l). The red bars the fall to the right of the ECOFF value are suggestive of resistant isolates. The blue bars indicate the WT isolates. Any 
data plotted at x=64mg/l represents organisms that hold an MIC that is greater than or equal to 64mg/l. 
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Figure 2:  Bar chart showing distribution analysis of MIC values for Oxytetracycline. The black arrow represents with the ECOFF cut off value is 
(16mg/l). The red bars the fall to the right of the ECOFF value are suggestive of resistant isolates. The blue bars indicate the WT isolates.  Any data 
plotted at x=64mg/l represents organisms that hold an MIC that is greater than or equal to 64mg/l. 
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Figure 3: Bar chart showing distribution analysis of MIC values for Cefquinome. The black arrow represents with the ECOFF cut off value is 
(8mg/l). The red bars the fall to the right of the ECOFF value are suggestive of resistant isolates. The blue bars indicate the WT isolates. Any 
data plotted at x=64mg/l represents organisms that hold an MIC that is greater than or equal to 64mg/l. 
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Figure 4: Bar chart showing distribution analysis of MIC values for Ampicillin. The black arrow represents with the ECOFF cut off value is 
(8mg/l). The red bars the fall to the right of the ECOFF value are suggestive of resistant isolates. The blue bars indicate the WT isolates. Any 
data plotted at x=64mg/l represents organisms that hold an MIC that is greater than or equal to 64mg/l. 
3.6 MIC v ZD calculations for E.coli on Farm 2 
 
The MIC concentrations for E. coli on Farm 2 were calculated according to the 
method described in 2.5. E. coli on Farm 2 were chosen to follow on from previous 
calculations for MIC on Farm 1. The MIC for Marbofloxacin, Cefquinome and 
Oxytetracycline were calculated and three technical replicates were performed. These MIC 
results were then used to determine levels of potential resistance against their antibiotics. The 
MIC value was then compared to the ZD value for each isolates shown in Figures 5 to 10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Scatter graph showing the average of the MIC replicates against ZD for Marbofloxacin for E. coli on Farm 2, showing standard deviations 
(blue squares represent the environmental samples; red diamonds represent samples taken from the bovine gut). 
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Figure 6: Scatter graph showing the average of the MIC replicates against ZD for Oxytetracycline for E. coli on Farm 2, showing standard deviations (blue 
squares represent the environmental samples; red diamonds represent samples taken from the bovine gut). Any data plotted at x=64mg/l represents 
organisms that hold an MIC that is greater than or equal to 64mg/l 
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Figure 7: Scatter graph showing the average of the MIC replicates against ZD for Cefquinome for E. coli on Farm 2, showing standard 
deviations (blue squares represent the environmental samples; red diamonds represent samples taken from the bovine gut). Any data plotted at 
x=64mg/l represents organisms that hold an MIC that is greater than or equal to 64mg/l. 
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Figure 8: Scatter graph showing the average of the MIC replicated against ZD for Ampicillin for E. coli on Farm 2, showing standard deviations 
(blue square represent environmental samples; red diamonds represent samples taken from the bovine gut).  Any data plotted at x=64mg/l 
represents organisms that hold an MIC that is greater than or equal to 64mg/l. 
 
The results for Marbofloxacin (Figure 18) showed a cluster towards the far left of the 
graph. The highest MIC concentration was 1mg/l. All Zone Diameter (ZD) values were above 
20mm. A ZD of 20mm was commonly deemed susceptible across most antibiotics according 
to EUCAST (2016) for Enterobacteriacae. This suggests that the majority E. coli in this study 
were susceptible to Marbofloxacin.  The results for Marbofloxacin showed only one distinct 
cluster, unlike the other three antibiotics.  
 
Oxytetracycline showed four distinct clusters (Figure 19). The four clusters can be 
seen at high MIC concentration values and at low MIC concentration values and at high and 
low ZD values. The largest cluster was seen at 64mg/l and 6mm. This is the opposite 
relationship than Marbofloxacin, which showed a cluster at lower MIC concentrations that 
were below 0.5mg/l and high ZD values. The other clusters also showed that some of the E. 
coli organisms were also susceptible to Oxytetracycline. Cefquinome also did not show one 
distinct cluster, however, the majority of results were towards the left of the scatter graph 
(Figure 20) where the organisms had low MIC values and a ZD value above 20mm. A second 
cluster is shown around 32mg/l for the MIC value and a ZD value above 20mm. The final 
small cluster formed at >32mg/l and low ZD values and this was also the cluster seen for 
Oxytetracycline. These clusters suggest the E. coli were both susceptible and resistant to 
Cefquinome and more strain variance was seen than with Oxytetracycline and 
Marbofloxacin. Ampicillin (Figure 21) showed three clusters, around 0-10mg/l, around 
32mg/l and at 64mg/l. The majority like in the cluster towards the lower MIC concentrations. 
As with Cefquinome, E. coli show variance within the isolates where some have lower ZD 
values and higher MIC concentration suggesting these isolates have resistance and those 
organisms that show high ZD values and low MIC concentrations to show susceptibility. The 
variances found in these results are similar to that stated by EUCAST (2016), where the 
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majority or the MIC concentrations ranged from 1-8mg/l being the most common and higher 
MICs also stated. Organisms that have a higher ZD and low MIC represent little or no 
resistance. Likewise, lower ZD values and high MIC represent organisms that have higher 
resistance towards an antibiotic. For an organism to have either a high ZD and a high MIC, 
shows a potentially contradictory conclusion. Further research is needed to conclude what the 
relationship between ZD and MIC represents in this case 
Within the data, organisms from the BG (red) and ENV (blue) were represented. No 
difference was seen between the two groups. This was not the case for the class resistance 
data or resistance that represented the species. This method could be used as an 
epidemiological tool for determining MICs and prevalence of resistance, environmental 
samples to represent the whole farm, with the herd included. 
 
 
4.10 Single v Dual Target  
 
 Antibiotics that work as a dual target contain more than one antibiotic class. In this 
instance. Amoxicillin was combined with Clavalunic acid and Piperacillin was combined 
with Tazobactam. Table 20 shows the percentage of resistance found in the single target and 
dual target antibiotics.  
Table 20: Table showing the percentage of bacteria showing resistance to these set 
antibiotics.  
 Farm 1 Farm 2 Farm 3 
Amoxicillin 84% 43% 66% 
Amoxicillin-Clavulanic 
acid 
20% 46% 39% 
Piperacillin 8% 20% 15% 
Piperacillin-Tazobactam 4% 34% 5% 
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The results do not show a direct relationship of resistance seen between single and dual target 
antibiotics, as the difference in percentage between the two varies in each example. Further 
studies are required to understand how dual target antibiotics can lower resistance, and if this 
is directly proportional to resistance seen against single target antibiotics.  
 
 
4.0 Discussion 
 
4.1 Antibiotic use and animal welfare 
 
For cattle, the predominant use of antibiotics is for the control of mastitis in dry cows, 
where antibiotic treatment may be giving for clinical of sub clinical mastitis (Briyne et al., 
2016). Dry cow therapy has traditionally used intramammary antibiotic therapy immediately 
after the last lactation. It is possibly that the extent of the use of antimicrobials used to control 
mastitis could be reduced if there was a wider awareness and application of best practice 
guidelines, such as the responsible use of medicines in agriculture (RUMA, 2005). The use of 
antibiotics during lactation to control mastitis and to reduce pain and inflammation is 
recognised as essential on welfare grounds. This should be accompanied with a suitable 
prescribing practice and regular bacterial isolation ad sensitivity testing. Having good animal 
husbandry, biosecurity and milking hygiene will help minimise mastitis without potential 
overuse of antibiotics (Briyne et al., 2016). The risks seen with the development of resistant 
bacteria can potentially be traced to intensive animal production, as well as mismanagement 
seen in nutrition, chemotherapy and housing conditions (Trevis et al., 2006). Good animal 
welfare is not only achieved through eliminating pain and disease but also by proper 
management of animal welfare (Loor et al., 2003). Poor animal welfare has commonly been 
used as the reason for antimicrobial resistance being found, however the farms involved in 
this study showed good animal welfare procedures ad yet high level of resistance were found. 
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This could potentially show that resistance may not come from mismanagement alone. 
Therefore further research is required to determine why high levels of resistance can be 
found, examples of which could be unknown. Further work is needed to determine what 
factors would case resistant organisms to survive in this environment. 
 
4.2 Antibiotic classes used on farm 
 
Section 3.2 showed the different antibiotics used on farm. There are only a few 1st and 2nd 
generation Cephalosporin approved worldwide for the treatment of mastitis infection, whilst 
Ceftiofur, a 3rd generation cephalosporin, and Cefquinome, a 4th generation cephalosporin, 
have been developed specifically for veterinary use (EMA, 1998). Cefquinome has been 
approved in several countries for the treatment of respiratory disease in cattle and swine, foot 
rot in cattle as well as mastitis in dairy herds (Hornish & Katarski, 2002). Ceftiofur and 
Cefquinome were used across all farms in this study.  In 2012, the Food and Drug 
Administration’s centre for veterinary medicine issued an order prohibiting certain used of 
cephalosporins in food producing animals. This was because cephalosporins are commonly 
used in treating human disease (FDA,  2014); cephalosporin was include in the CIA for the 
same reason. Although these restrictions are set, all generations of cephalosporin are still 
being used across farms and resistance towards them is seen. All farms used cephalosporins 
in this study and resistance was seen (Table 7,8 and 9).  
 
Tetracyclines are commonly used in animal husbandry; in some food producing animal 
species they are the first line of therapy (EMA, 2013).  Tetracyclines are the most commonly 
sold antimicrobial in veterinary medicine: in the UK 46% of the antibiotics used for food 
producing animals were tetracycline in 2010 (ESVAC, 2012). Because Tetracycline are 
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commonly used, they were one of the first antibiotic classes to show resistance in initial 
studies (Schwarz & Dancla, 2001). Several different mechanisms of tetracycline resistance 
were noted, with active efflux pumps and ribosome protection being the most prevalent 
(Schwarz & Dancla, 2001).  Tigecycline is a form of Glycylcycline, which is a new antibiotic 
derived from tetracyclines, designed to overcome common mechanisms of tetracycline 
resistance. The two mechanisms are resistance mediated by acquired efflux pumps and/or 
ribosomal protection. Tigecycline is authorised only for human use, treating complicated skin 
and soft tissue infections (EMA, 2013). It is also authorised by the FDA (2006) for 
community-acquired pneumonia.  Currently Tigecycline resistance has been mostly seen in 
human medicine and has not been recognised in veterinary medicine (EMA, 2013). A study 
by Ruzauskas (2009) showed only 2% Tigecycline resistance amongst isolates taken from 
cattle, swine and poultry.  This study showed higher levels of resistance against Tigecycline, 
even though the antibiotic as not used. Further studies would determine whether this is an 
example of cross over resistance or class resistance, due to the large use of tetracycline across 
the three farms.  
 
Carbapenems are not a commonly used antibiotic class for veterinary medicine in large 
animals (Dowling, 2013), which may be why little resistance was seen compared to other 
classes in this study. Ciprofloxacin was the only fluroquinolone being tested in this study. 
Fluroquinolones use in human medicine is commonly used and so agricultural use of this 
class is low to prevent the selection pressure for pathogens to develop resistance (McEwan & 
Fedoraka, 2002). Pencillins,  specifically Amoxicillin is one of the older antibiotics available 
and sued in both human and veterinary medicine. This is unlike Gentamicin which is rarely 
used in cattle and more commonly used in human medicine. A study by Schroder et al., 
(2002) showed that gentamicin had a lower prevalence of resistance in E.coli at 18.6% in 
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cattle; ampicillin was also low at 12%. The aim of investigating a wide range of antibiotics 
was to begin developing a clear understanding as to what possible resistance can be seen on 
farm. 
 
 
4.3 Resistance in the BG and ENV 
All three farms showed different resistance profiles in the isolates taken in the BG and 
ENV. Likewise different resistant profiles for different species isolatd were also seen across 
the three farms. All three farms were exposed to similar classes of antimicrobials and this 
was seen in the resistance profiels between Farm 1 and Farm 2 but could not be noted in 
Farm 3. Fluroquinolones were not prescribed on Farm 3 and resistance against the class was 
still seen (table 9). The reason for this could not be determined, and further studies into farm 
biosecurity and its potential effect are required to determine how this is possible.  
 
The different resistant profiles from the isolates in the ENV could be due to the antibiotics 
being directly excreted through animal faeces and resistance in the bacteria themselves being 
excreted. The isolates in the ENV come from the different cattle who are being exposed to 
different antibiotics. After administration of an antibiotic, a significant fraction is excreted in 
either the parent form or their active metabolite )Zhou et al., 2013). The percentage that this 
would occur at differs among different antibiotics depending on their stability. Antibiotic 
residues have been reported in the surrounding environment on farms, where the 
concentration can range from 26-83µg/g in soils (Li et al., 2011). When antibiotics are 
introduced in this way, they could potentially cause development of antibiotic resistance 
through exerting a selective pressure on the microbial community (Pruden et al., 2006). This 
supports the different profiles of resistance found in the ENV in this study, and where the 
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percentage of resistance against certain antibiotic classes of antibiotic were higher in the 
ENV than in the BG samples. Pseudomonas sp. On Farm 3 (table 9) is an example of higher 
resistance seen in the ENV than in the BG.  It is possible that as the antibiotic is excreted 
from the cow into the environment, selective pressures cause the surrounding bacteria in the 
ENV to become resistant in order to survive against the introduction of new antibiotics into 
its surroundings. As most antibiotics are water soluble, many that are used in the cattle 
industry are poorly absorbed in the bovine gut resulting in up to 90% of the compound being 
excreted before it can be metabolised (Zhao et al., 2010).  Antimicrobials are designed to 
overcome this factor by having physiochemical properties that allow absorption, distribution 
and bioavailability within the bovine gut (Dowling, 2013). However, excretion of the 
compound can still be observed. Different antibiotics were excreted into the same 
environment and potentially allowing the bacteria to pick up or develop multiple resistance 
mechanisms from the surroundings. This is observed in section 3.3, where bacteria with 
resistance against multiple classes, were more widely seen in the ENV samples than in the 
BG samples. It was seen that an organism can have resistance to more than one class of 
antibiotic. 
 
It is known that the addition of antimicrobials into the gut of any species will eliminate 
antibiotic sensitive bacteria and allow the populations density of the resistant bacteria to 
increase (Campagnolo et al., 2002). Therefore, when samples were taken from faecal matter 
representing the BG, it is likely that multiple resistant organisms can be present, as shown in 
section 3.3. Both the ENV and BG provide the opportunity for organisms carrying resistance 
to survive over antibiotic sensitive bacteria. However with more multi resistance bacteria 
being found in the ENV, it is possible that the bacteria in the environment are able to better 
hold resistance to multiple classes of antibiotic that in the BG. This may be that the properties 
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of the surroundings in the ENV favour this more than in the BG and further studies are 
required to determine the reason for this. There are different physiological and chemical 
properties within the two different environments of the BG and END. The bacteria in the BG 
are not exposed to weather conditions and likewise the bacteria in the ENV are not exposed 
to the conditions found in the BG: different levels of acidity as well as an immune system 
found in the gut eco system. This makes it difficult to compare the two sets of data. This is 
because both are facing different selective pressures and so make them directly 
incomparable. The two environments hold differences in the selective pressures and 
exposure; yet still interact with one another causing a potential movement of organisms 
between the two. Animal faeces can be found in the environment and cattle can pick up 
resistant organisms from contact within the environment. These factors could suggest that the 
movement of organisms overcome the factors influencing the individual environment.  
4.4 Determining ECOFFs 
 
EUCAST defines the Epidemiological cut-off value (ECOFF) as an MIC value that 
identifies the upper limit of the wild type (WT) population. The ECOFF value can be 
determined by visual inspection or through statistical calculation (Turnbridge et al., 2006). 
An example of a visual inspection is the commonly used “eyeball method” to determine cut 
offs. While this method can be applied as "estimation”, it can lack reproductively (Valsesia et 
al., 2015). Nonetheless, the method was successfully used by Keller et al. (2015) and showed 
ECOFFS can be determined through finding the frequency of MIC values. This method was 
used for determining the ECOFFs in the isolates from this study. 
The distribution analysis shows variation between the antibiotics. Marbofloxacin 
(figure 5 showed a trend of low MIC concentrations associated with high ZD values 
(Appendix D), the ECOFF was low at 0.5mg/l. Likewise for Oxytetracycline (figure 6), the 
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ECOFF was 16mg/l and the cluster where there were high MICs and low ZDs are represented 
in the orange bars for suggestive resistant isolate. Where there was also a cluster towards the 
other end of the values, part of a normal distribution cure was seen and so the ECOFF was 
determined. Ampicillin (figure 8) has the same ECOFF value as Oxytetracycline, however 
the prevalence of suggestive resistant strains is much smaller and a whole normal distribution 
curve can be seen. The ECOFF for Ampicillin according to EUCAST (2016) is 8mg/l. It is 
possible that the ECOFF is different due to the fact that EUCAST works with human samples 
and the strains studied here have come from cattle. Oxytetracycline shows a similar profile to 
that of Ampicillin. Cefquinome’s ECOFF value of 8mg/l falls in the middle of the ECOFFs 
found in this study (Figure 7. Like Ampicillin, a whole normal distribution curve can be 
noted, although it is weighted to the left, similar to Marbofloxacin. Cefquinome and 
Ampicillin hold similarities, but the distribution for Cefquinome is shifted far to the left 
where there are lower MIC concentrations, makes its less comparable that Oxytetracycline. 
 
4.5 Human and veterinary antibiotics 
 
Antibiotics designed for human use may not have the same attributes that are required for 
effective dosing and treatment in animal healthcare. Different antibiotics in one class can 
hold different chemical elements changing their efficacy. Different generations seen in 
Cephalosporin and the addition of Clavulanic acid to Amoxicillin are examples of where 
there are differences seen within the group of antibiotics in one class. Cephalosporin is 
generally stable against the plasmid mediated β-lactamases produced by both Gram positive 
and Gram negative bacteria. Several types of β-lactamases produced may be mediated by 
either plasmid of chromosomally and may hydrolyse either/both penicillin and cephalosporin, 
causing cross resistance. 2nd and 3rd generation Cephalosporin have a greater reaction against 
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Gram negative β-lactamases compared to 1st generation (Boothe, 2015). The addition of 
clavulanic acid to Amoxicillin acts as a β-lactamase inhibitor to improve its treatment against 
resistant bacteria. The disadvantage of developing antibiotics this way to improve efficacy is 
the limit of additions to its analogue which can be a single chemical core or ones which can 
counteract resistance mechanisms (Coates et al., 2011). Furthermore, antibiotic 
concentrations can be very different in different tissues and organs, which complicate the 
determination of therapeutic thresholds. Likewise, antibiotics used in humans and cattle 
cannot be deemed to have the same effects due to different tissues, size and organs and 
pharmacokinetics (Rodloff et al., 2008).  
Intermediate values, according to EUCAST (2016) were commonly seen against the 
human antibiotics tested in this study. Antibiotics with this intermediate value were 
Gentamicin and Tigecycline. The use of intermediate values could be used as a buffer to 
prevent the fluctuating interpretation of the results that are susceptible at some points and 
resistant at others merely due to minor, random variation in test conditions (Rodloff et al., 
2008). The classification of “intermediate” also represents antibiotics that are effective 
against one organism in one target site, for example the urinary tract, but is not as effective in 
another target site. This is due to the pharmacodynamics and pharmacokinetics of the 
antibiotic (Rodloff et al., 2008).  
4.6 Cross resistance 
 
All antibiotics used in veterinary medicine are the same or closely related to antimicrobials 
used in human medicine which will induce cross resistance (Ungemach et al., 2006). When 
looking more closely, molecular mechanisms could provide insight as to how resistance can 
carry over across species and antibiotic classes. Molecular analysis of antibiotic resistant 
genes, plasmids and transposons has demonstrated identical elements found in humans and 
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animals. The mobile genetic elements can move from animals to humans through the 
environment (Ungemach et al., 2006). For example, bacteria are released into the 
environment through animal faeces, carrying resistance with it. Specific food items, water 
and direct contact can spread the bacteria from animal’s microflora to human microflora 
(Tueber, 2001).  
It is also possible that cross resistance is seen through the different classes having the 
same resistant mechanisms. Most antibiotics are targeted at intracellular processes, and must 
be able to penetrate the bacterial cell envelope. In particular, the outer membrane of Gram – 
negative bacteria provide a formidable barrier that must be overcome. There are essentially 
two pathways that antibiotics can take through the outer membrane: a lipid-mediated pathway 
for hydrophobic antibiotics and general diffusion pores for hydrophilic antibiotics (Delcour, 
2009). Aminoglycosides, older Tetracyclines (including Oxytetracycline) and β-lactams are 
hydrophilic and so can use simple diffusion to enter the cell. Modification in the outer 
membrane, like changing the lipid and/or porin composition, will influence the antibiotic’s 
ability to enter the cell (Delcour, 2008). This means that the organism is able to be resistant 
to different classes of antibiotic with only one mechanism.  
Efflux pumps alongside low permeability can cause synergy and multidrug resistance, 
especially with Pseudomonas sp. (Schweizer et al., 2003).  A documented mechanism to 
reduce outer membrane permeability was to lower porin expression through environmental 
factors or mutations (Delcour, 2009). For example, the uptake of tetracycline by E. coli cells 
were shown to be reduced in a mutant lacking OmpF expression confirming that tetracycline 
use the pathway of diffusions through porins based on increase resistance in mutants with 
decreased OmpF expression (Cohen et al., 1988). The upregulation of the marA gene leads to 
increased levels of sRNA micF which inhibits translation of OmpF RNA and this decreased 
expression leads to increased resistance (Delcour, 2009). This is an example of where gene 
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mediated antibiotic resistance is used and so in this case cells become insensitive to a variety 
of hydrophilic antibiotics as listed above.  
 
4.7 Single target versus dual target antibiotics  
Dual target antibiotics were created to improve the efficacy of the treatment. 
Amoxicillin is a first choice narrow-spectrum antibiotic; its combination with Clavulanic 
Acid is suggested to the treatment of patients with suspected Gram negative infections caused 
by β-lactamases-producing organisms. Clavalunate is able to inactivate β-lactamases, which 
prevents penicillin degradation and consequently antimicrobial resistance (Salvo et al., 
2007). In this study Amoxicillin, Piperacillin, Amoxicillin-clavulanic acid, Piperacillin-
Tazobactam was used as examples to see the difference between single and dual target 
antibiotics. Below show the percentage of bacteria resistant to these antibiotics. 
 
The combination of clavulanic acid should make for a better antimicrobial that can 
work against strains which would be resistant to amoxicillin alone. Tazobactam would have a 
similar effect. As β-lactamase production by both Gram-positive and Gram negative 
pathogens become a clinically relevant issue, efforts were made to develop an orally 
bioavailable broad spectrum penicillin that was also effective against these strains, resulting 
in the combination of amoxicillin and clavulanic acid, the combination with clavulanic acid 
increases the effect of amoxicillin and inhibits the development of resistance in β-lactamases 
(Kaur et al., 2011). This is seen in the farms, except for with Farm 2, the only farm that uses 
Amoxicillin on its own as well as with Clavulanic acid.  
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4.8 MIC study 
The need for clinical breakpoints for veterinary pathogens is needed (Supre et al., 
2014). The need for accurate clinical breakpoints for veterinary pathogens is high (Supre et 
al., 2014). Oxytetracycline, Marbofloxacin and Cefquinome are common antimicrobials in 
veterinary healthcare, their clinical breakpoints are yet to be determined. A breakpoint setting 
requires integrated knowledge of Wild Type (WT) distribution of MICs and an assessment of 
pharmacodynamics and pharmacokinetics (Turnbridge et al., 2011). This can be achieved by 
performing a population study focussing on the distribution of inhibition zones diameters on 
the condition that a large number of strains are tested (Supre et al., 2014).  This study begins 
to examine this by comparing the ZD with the MICs and looking at WT distribution with the 
focus driven towards determining ECOFFs. ECOFF values help determine which strains are 
part of the WT population and which are not. This information alongside breakpoints and 
MICs can collectively start to create an analysis are to what resistance can be seen. ECOFFs 
are often unavailable for studying veterinary pathogens by disc diffusion or other methods, 
and in addition, ECOFFs and clinical breakpoints and not necessarily linked (Schwarz, 
2010). It is important to note that this information alone, and the data collected and shown in 
secntion 3.4,  cannot conclusively determine resistance profiles but it is the first steps in 
determining breakpoints are providing food distribution analysis of the population.  
MIC variation between the four antibiotics shows strain variance to susceptibility of 
antibiotics. The Bacteria showed most susceptibility to Marbofloxacin with the lowest MIC 
values, Oxytetracycline saw much higher MICs –of greater than 32mg/l. For Cefquinome and 
Ampicillin there was more variation with MICs falling towards lower and high 
concentrations. Where this potentially begins to show differences in the antibiotics, MIC 
distribution is not enough to determine susceptibility or resistance of organisms. This is why 
using ZD values adjoined to MIC for comparison is important to show potential clinical 
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success or failure. Clinical testing enables analysis of the relationship between MIC values of 
the infectious organisms and the clinical and microbiological results of treatment (Pai et al., 
2007). 
 
MIC values are not comparable against other MIC values; the concentration only represents 
the MIC for that particular patient, antibiotic and origin (patient or animal). However, when 
using the ZD and MIC together it is able to compare the data. MIC values represent 
inhibition of growth of a strain, similar to a ZD, which represents the area of media where 
bacteria are unable to grow due to the presence of antibiotic. In other words, the drug 
presence is potentially impeding the growth of the organism. Therefore, low MIC values 
indicate that less drug is required for inhibiting the growth of the organism. This means those 
E. coli strains are potentially more susceptible to the antibiotic. A clear example of this is that 
data seen with Marbofloxacin. The MIC did not exceed 1mg/l (Figure 5). Likewise, high ZD 
values show that more organisms perish when exposed to this concentration. A high ZD 
value and low MIC value are associated with each other.  
 
Marbofloxacin is a third generation cephalosporin, seen as one of the critically important 
antimicrobials not to be used to stop resistance. The lack of use of the antimicrobials is 
echoed in the results for the MIC and ZD. The ECOFF value for Marbofloxacin is low at 
0.5mg/l and the ZD values were generally quite high. These results show a population that is 
highly susceptible to the antimicrobial with little variation in the species population. This 
supports the notion that lack of exposure to an antimicrobial will mean the organism may 
have either lost the resistance genes required to survive in the current environmental setting 
or not have developed the resistance initially. Epidemiological studies show a direct 
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correlation between overuse of antimicrobials and emergence of resistance (Ventola, 2015). 
Therefore, the opposite should also be true, and this evidence supports this. 
 
Likewise, high MIC concentrations an low ZD values will be associated with one another, 
but this time would show potentially resistant strains. This is seen with Oxytetracycline 
(Figure 6) , where multiple strains of E. coli had an MIC concentration >32mg/l and a ZD 
that was less than 9mm. Further tests are needed at higher concentrations to determine the 
exact MIC value. This is similar to the some of the results for Ampicillin and Cefquinome yet 
the same cannot be said for Marbofloxacin. 
 
Oxytetracycline and Ampicillin showed the same ECOFF at 16mg/l (figure 6 and 8 
respectively). This was higher for Ampicillin that suggested by EUCAST (2016) at 8mg/l 
(figure 8) However, it is important to consider that this is for strains taken from humans and 
not from cattle. Whilst these two antibiotics have the same values, many more strains fell 
above this value and so would be considered part of the WT population and instead show 
resistance. This is also supported by the high number of strains having a ZD value lower than 
9mm and many strains forming a cluster at the bottom right of the graph; having both high 
MIC values and low ZD. 
 
Some strains showed high ZD values and also high MICs, also some strains showed low 
values for both. To have these set of values contradict what the values represent. If a sample 
is to have a low MIC values and so show high susceptibility, it is not then expected to have a 
low ZD value representative of a resistant strain. While there are strains that show this 
relationship, they still belong amongst the WT population, as shown by the ECOFF value. 
This is mostly seen with Cefquinome with data that have low MICs and low ZD values. This 
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suggests that the strains are showing variance in the sensitivity towards the antibiotic, yet no 
resistance can be detected with these values for the strain. Strains that have a higher MIC 
than the ECOFF value have a low ZD and high MIC and can suggest potential resistance. 
These types of results help distinguish WT from non-WT and thereby recognise potential 
resistance in a clinical practice (Bruin et al., 2013).  Therefore, although the breakpoints need 
to determine strains that are resistant are not available, most potentially seen with 
Oxytetracycline, these results can determine a potential resistance profile in a clinical 
practice. Another explanation for strains with these values is the presence of small colony 
variants. Small colony variants are a slow growing subpopulation of bacteria with distinctive 
phenotypic and pathogenic traits. Clinically, small colony variants are better able to persist 
within the mammalian cell population and less susceptible to antibiotics than their wild type 
counterparts, and can cause latent or recurrent infections on emergence from protective 
environments of the host cell (Proctor et al., 2006).  This can explain why bacteria are 
showing counteractive values, they have the ability to hold high MIC values but when tested 
ZD; they have large diameters showing large susceptibility. The bacteria show different 
phenotypic traits within the WT population.  
 
No differences were seen between the samples from the BG and ENV. This suggests that if 
further surveillance was to be conducted, through choosing an environmental location that 
represented the microbial activity of the whole farm. Surveillance is the main method for 
understanding the spread of resistance and monitoring how resistance in pathogens rises and 
falls. By showing that samples for data such as the results shown here can be obtained by 
using environmental samples will allow for a simpler method that can be as effective. Further 
research is needed to depict which environmental location can represent the herd and farm 
profile.  
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4.9 Statistical Analysis 
 The results of the statistical analysis did not show enough statistical signifagance 
which meant only assumptions could be made for the data. Statistical signifigance of the data 
could be achieved by increasing the population size of the data. This would be done through 
conducting more surveillance studies over longer periods of time.  
 
 
5.0 Conclusion 
Surveillance of resistance and antibiotic use is one of the main methods that can be used 
to help tackle the issue of antibiotic resistance. Information obtained from antimicrobial 
surveillance is important for establishing trends in pathogen antimicrobial resistance and for 
identifying emerging pathogens across all environments (Masterton, 2008).   
 
The resistance profiles have shown what levels of resistance can be found at one point during 
the year for the herd and surrounding environment. There were clear differences between the 
samples taken from the BG and from the ENV within one farm and then again between all 
three farms enrolled. Differences within the targeted species were also seen and species on one 
farm would not have the same profile as found on the other two. What was evident within the 
results, however, were that high levels of resistance are present both on farm and in the herd 
themselves. The MIC results started to show a pattern between the MIC and ZD and that it is 
possible to determine a resistant trend without the use of set clinical breakpoints. For example, 
there was a high level of resistance towards Oxytetracycline, with very small ZD values and 
high MIC concentration which when correlated together, highlighted the difference between 
mutant and WT strains and the prevalence of resistance against that organism. Meanwhile, the 
exact opposite was able to be determined with Marbofloxacin. 
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The use of prescription data, shown in 3.1, gave a small insight as to how prescription 
patterns can be linked to trends into resistance but more research is needed to determine how 
antibiotics react to one another as well as cause resistance as it becomes evident that herds in 
the cattle industry can be regularly exposed to different antibiotics at differing doses. This 
exposure pattern differs greatly to that seen in human healthcare. Human healthcare allows 
precise recording of antibiotic use and this is not seen in animal healthcare. This should be 
introduced to allow better understanding of the spread of resistance organisms. The inability 
to identify trends in exposure to antibiotics and resistance stops the opportunity for a better 
understanding as to how antibiotic use affects resistance in food –producing animals, and so 
stops relating the research to its effect on human healthcare. This study has shown the 
important and relevance of One Health. The One Health initiative aims to equalise the work 
and research effort to combine and understand relevant issues between specialists. The 
antimicrobial resistance that is seen in animal and human healthcare support the movement 
of organisms from on to the other and also impact the environment. Combining the efforts 
and research can improve surveillance of the resistant organisms: understanding their origin 
and evolution and so finding how to stop their spread of infection.  
 
5.1 Future work 
 
This study can only be considered as a snapshot of the profiles of resistance that can be 
found on farm. It is clear that routine monitoring of antibiotic resistance levels on farm is 
necessary. Relating these findings to antibiotic use on farm can help monitor antibiotic 
resistance profile in the healthy herd and so be of us in limiting the rise of resistant bacterial 
strains on farm locations and in individual animals. The overall aim with regard to 
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antimicrobial resistance is to determine effective use of antibiotics, to ensure to animal 
welfare is still kept to a high level and antibiotics are used prudently. 
 
Longitudinal studies will also help research to see how these resistance profiles change over 
time, and whether the movement of resistant organisms can be monitored and possibly 
predicted in the future. By understanding the movement of resistance on farm, a better 
understanding as to how resistance moves from animal to human could also be achieved.  
This means that the risks seen in human healthcare will also potentially become less. At the 
moment the rise of resistance and uncertainty of resistance origin has dictated how antibiotics 
are used. This leaves multiple classes of antibiotics to no longer be available of use for 
animal healthcare due to the limited treatment options in human healthcare. If these studies 
can show how resistance evolves over time it will allow better understanding of the effects of 
antibiotic use in a lot more detail.  
 
This study could have been further improved by als enrolling beef farms into the study. This 
would allow a comparison between the different types of farming among the cattle industry. 
Enrolling a beef farm will also allow species variation, as different species of cattle are used 
between the beef and dairy industry, and a potential increase in the number of organisms 
isolated and identified. The MIC study could further improve by looking at the MICs for all 
species across the three farms. Looking at the MIC variation between the different species 
and farm will also add to determining clinical breakpoints for those set antibiotics. MICs are 
not a set value and can change over a few months, tracking the changes will help to 
understand how susceptibility to the antibiotic changes. Further work with the environmental 
samples can determine how weather affects the resistance found in the environment. 
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Many countries have seen a pressure to decrease the number of antibiotics prescribed. 
The movement from DCT to SDCT is one example of this. However, antibiotic treatment is 
still effective; it is only through misuse that it becomes ineffective.  Antibiotic treatment 
should still be seen as a form of therapy and prudent use of antimicrobials should be 
welcomed. This can be achieved by recognising those that follow guidelines for correct 
antibiotic use. A proposed charter would allow recognition for correct antimicrobial use 
while increasing public awareness of the issue regarding antimicrobial resistance. Those who 
qualify to be awarded the charter that shows responsible antibiotic use will be recognised as a 
business that used the antibiotics correctly and so are helping to improve the issue of 
resistance. The Responsible Antibiotic Use Charter (RUAC) can be awarded after a series of 
steps are achieved, for example a workshop teaching farmers about what the different 
antibiotics are and importance of correct dosing and treatment. Farms involved in the RUAC 
can be part of the longitudinal study the looks at resistance over time across different farm 
locations in different geographical areas. Conducting this study on a much larger scale will 
improve the efficacy of the study and allow a better understanding of on farm resistance.  
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